Spreadsheet: 55573df9-ce72-4d9d-8102-7df9ae7147c9
Sheet: Sheet1

Cumulative List of all Products that have received Orphan Designation: Total active designations: 2002      Effecive: 5/5/2009 | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6 | Unnamed: 7 | Unnamed: 8 | Unnamed: 9 | Unnamed: 10
Generic Name | Trade Name | Designated Indication | Marketing Approved Indication
[NAME] (Human) Intravenous | CNJ-016 | Treatment of complications of vaccinia vaccination | treatment and/or modification of the following conditions, which are complications resulting from smallpox vaccination: Eczema vaccinatum Progressive vaccinia Severe generalized vaccinia Vaccinia infections in individuals who have skin conditions such as
Antihemophilic factor (recombinant) | [NAME] | For the control and prevention of hemorrhagic episodes and for surgical prophylaxis in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia).
Potassium Iodide Oral Solution | ThyroShield | For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine | For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine
[NAME] surfactant replacement, porcine | Curosurf | For the treatment and prevention of respiratory distress syndrome in premature infants. | Treatment (rescue) of respiratory distress syndrome in premature infants.
Somatropin (rDNA origin) | [NAME] | Treatment of idiopathic or organic growth hormone deficiency in children with growth failure. | Long term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone.
Somatropin (rDNA origin) | Nutropin Depot | Long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion. | Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration.
Somatropin (rDNA origin) injection | Norditropin | Treatment of growth failure in children due to inadequate growth hormone secretion. | Long-term treatment of children who have growth failure due to inadequate secretion of endogenous growth hormone.
Surface active extract of saline lavage of bovine lungs | Infasurf | Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants. | Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.
Trypan blue | MembraneBlue | Selectively staining epiretinal membranes during ophthalmic surgical victrectomy procedures | For use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue
Recombinant human antithrombin | [NAME] | Treatment of congenital antithrombin deficiency to prevent the occurrence of serious, potentially life-threatening venous thromboembolisms which may develop as a result of surgical or obstetrical procedures | Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.
human fibrinogen concentrate, pasteurized | [NAME] | Treatment of fibrinogen deficient patients | Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia
Fludarabine phosphate oral tablets |  | Treatment of B-cell chronic lymphocytic leukemia | Treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen
plerixafor | Mozobil | For use to improve the yield of progentor cells in the apheresis product for subsequest stem cell transplantation following myelosuppressive or myeloablative chemotherapy | To enhance mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma
eltrombopag | [NAME] | Treatment of idiopathic thrombocytopenia purpura | Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
rufinamide | Banzel | Treatment of Lennox-Gastaut Syndrome. | Adjunctive therapy of seizures associated with Lennox-Gastaut syndrome.
C1 esterase inhibitor (human) | Cinryze | Treatment of angioedema | Routine prophylaxis against angioedema attacks in patients with [NAME] (HAE)
Iobenguane I 123 | AdreView | For the diagnosis of pheochromocytomas | To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests
Iobenguane I 123 | Adreview | For the diagnosis of neuroblastomas | To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests
Immune Globulin (Human) | [NAME] | Treatment of chronic inflammatory demyelinating polyneuropathy | Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse
romiplstim | Nplate | Treatment of immune thrombocytopenic purpura | Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
Tetrabenazine | Xenazine | Treatment of Huntington's disease | Treatment of chorea associated with Huntington's disease
Sorafenib | Nexavar | Treatment of hepatocellular carcinoma | Treatment of unresectable hepatocellular carcinoma
Bendamustine hydrochloride | Treanda | Treatment of chronic lymphocytic leukemia | Treatment of patients with chronic lymphocytic leukemia
Levoleucovorin |  | For use in conjunction with high-dose methotrexate in the treatment of osteosarcoma. | Levoleucovorin rescue is indicated after high-dose methotrexate therapy in osteosarcoma. Levoleucovorin is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid
Rilonacept | Arcalyst | Treatment of CIAS1-Associated Periodic Syndromes | Treatment of Cryopyrin-Assisted Periodic Syndromes (CAPS)
Adalimumab | Humira | Treatment of juvenile rheumatoid arthritis | Treatment of Juvenile Idiopathic Arthritis
Thyrotropin alfa | Thyrogen | Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid | For use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer
sapropterin | [NAME] | Treatment of hyperphenylalaninemia | Indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU).  [NAME] is to be used in conjunction with a Phe-restricted diet.
Nilotinib | Tasigna | Treatment of chronic myelogenous leukemia
[NAME] | [NAME] | Reduction of the risk of breast cancer in  postmenopausal women
dexrazoxane | Totect | Treatment of anthracycline extravasation during chemotherapy
Lanreotide | Somatuline Depot | Treatment for acromegly
[NAME] | [NAME] | Treatment of pulmonary arterial hypertension
Somatropin | Norditropin | Treatment of short stature in patients with Noonan syndrome
Temsirolimus | Torisel | Treatment of renal cell carcinoma
[NAME] liposome injection | Doxil | Treatment of multiple myeloma
Histrelin | Supprelin LA | Treatment of central precocious puberty
hepatitis B immune globulin (human) | HepaGam | Prevention of hepatitis B recurrence following orthotopic liver transplant
Protein C concentrate | Ceprotin | For replacement therapy in congenital protein C deficiency for the prevention and treatment of thrombosis, pulmonary emboli, and purpura fulminans.
eculizumab | [NAME] | Treatment of paroxysmal nocturnal hemoglobinuria
Antihemophilic factor (human) | Alphanate | Treatment of von Willebrand's disease
Balsalazide disodium | Colazal | Treatment of pediatric patients with ulcerative colitis
Hydroxocobalamin | Cyanokit | Treatment of acute cyanide poisoning
Imatinib mesylate | [NAME] | Treatment of systemic mastocytosis without the D816V c-kit mutation
Imatinib mesylate | [NAME] | Treatment of myeloproliferative disorders/myelodysplastic syndromes associated with platelet-derived growth factor gene re-arrangements
Imatinib mesylate | [NAME] | Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia
imatinib mesylate | [NAME] | Treatment of Philadelphia-positive acute lymphoblastic leukemia
imatinib mesylate | [NAME] | Treatment of dermatofibrosarcoma protuberans
Coagulation factor VIIa (recombinant) | NovoSeven | Prevention of bleeding episodes in patients with acquired inhibitors to Factor [NAME] or Factor IX
Coagulation Factor VIIa (Recombinant) | NovoSeven | Treatment of bleeding episodes in patients with acquired inhibitors to Factor [NAME] or Factor IX
vorinostat | Zolinza | Treatment of T-cell non-Hodgkin's lymphoma
biocarbonate infusate | Normocarb HF | Use in the management of patients undergoing continuous renal replacement therapy with hemofiltration
idursulfase | Elaprase | Long term enzyme replacement therapy for patients with mucopolysaccharidosis II (Hunter Syndrome)
lenalidomide | Revlimid | Treatment for multiple myeloma
Dasatinib | Sprycel | Treatment of Philadelphia-positive acute lymphoblastic leukemia
Dasatinib | Sprycel | Treatment of chronic myelogenous leukemia
Thalidomide | Thalomid | Treatment of multiple myeloma
[NAME] | REMICADE | Treatment of pediatric (0 to 16 years of age) Crohn's Disease
Decitabine | Dacogen | Treatment of myelodysplastic syndromes.
Recombinant human acid alpha-glucosidase | Myozyme | Treatment of glycogen storage disease type II.
Ibuprofen lysine | NeoProfen | Treatment of patent ductus arteriosus.
Tacrolimus | Prograf | Prophylaxis of organ rejection in patients receiving heart transplants.
[NAME] | Erbitux | Treatment of squamous cell cancer of the head and neck in patients who express epidermal growth factor receptor.
lenalidomide | Revlimid | Treatment of myelodysplastic syndromes
Sorafenib | Nexavar | Treatment of renal cell carcinoma.
mecasermin rinfabate | iPLEX | Treatment of growth hormone insensitivity syndrome (GHIS)
oxybate | Xyrem | Treatment of narcolepsy
Deferasirox | Exjade | Treatment of chronic iron overload in patients with transfusion-dependent anemias
nelarabine | Arranon | Treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma
Mecasermin | Increlex | Treatment of growth hormone insensitivity syndrome.
Coagulation factor VIIa (recombinant) | NovoSeven | Prevention of bleeding episodes in patients with hemophilia A or B, with or without inhibitors
quinine Sulfate |  | Treatment of malaria
meloxicam | [NAME] | Treatment of juvenile rheumatoid arthritis
Coagulation factor VIIa (recombinant) | NovoSeven | Prevention of bleeding episodes in patients with congenital Factor VII  deficiency
Coagulation factor VIIa (recombinant) | NovoSeven | Treatment of bleeding episodes in patients with congenital factor VII deficiency
N-acetylgalactosamine-4-sulfatase, recombinant human | [NAME] | Treatment of mucopolysaccharidosis Type VI (Maroteaux-Lamy syndrome).
Fluocinolone | [NAME] | Treatment uveitis involving the posterior segment of the eye.
Bortezomib | Velcade | Treatment of multiple myeloma
temozolomide | Temodar | Treatment of malignant glioma
[NAME] (Human) Intravenous |  | Treatment of severe complications from the smallpox vaccine
benzoate/phenylacetate | Ammonul | Treatment of acute hyperammonemia and associated  encephalopathy in patients with deficiencies in enzymes of the urea cycle.
Iloprost inhalation solution | Ventavis | Treatment of pulmonary arterial hypertension
clofarabine | Clolar | Treatment of acute lymphoblastic leukemia
Recombinant human luteinizing hormone | [NAME] | For use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism.
multi-vitiam infusion without vitamin K | M.V.I.-12 | Prevention of vitamin deficiency and thromboembolic complications in people receiving home parenteral nutrition and warfarin-type anticoagulant therapy
Diethylenetriaminepentaacetic acid (DTPA) |  | Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination.
Glutamine | NutreStore | For use with human growth hormone in the treatment of short bowel syndrome (nutrient malabsorption from the gastrointestinal tract resulting from an inadequate absorptive surface).
azacitidine | Vidaza | Treatament of myelodysplastic syndromes
tinidazole | Tindamax | Treatment of giardiasis
Tinidazole | Tindamax | Treatment of amebiasis
Apomorphine HCl | Apokyn | Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.
cinacalcet | Sensipar | Treatment of hypercalcemia in patients with parathyroid carcinoma
pemetrexed disodium | Alimta | Treatment of malignant pleural mesothelioma
acetylcysteine | Acetadote | For the intravenous treatment of moderate to severe acetaminophen overdose
Somatropin (r-DNA) | Zorbtive | For use alone or in combination with glutamine in the treatment of short bowel syndrome.
Botulism immune globulin | BabyBIG | Treatment of infant botulism.
iron(III)-hexacyanoferrate(II) | Radiogardase | Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium
porfimer | Photofrin | For the ablation of High-Grade Dysplasia in [NAME]'s Esophagus in patients who are not considered to be candidates for esophagectomy
miglustat | Zavesca | Treatment of Gaucher disease.
ribavirin | REBETOL | Treatment of chronic hepatitis C in pediatric patients
[NAME] and iodine I 131 tositumomab | [NAME] | Treatment of [NAME] B-cell lymphoma.
bortezomib | Velcade | Treatment of multiple myeloma
laronidase | [NAME] | Treatment of patients with mucopolysaccharidosis-I.
Ceramide trihexosidase/alpha-galactosidase A | Fabrazyme | Treatment of Fabry's disease.
Pegvisomant | Somavert | Treatment of acromegaly.
polifeprosan 20 with carmustine | Gliadel | Treatment of malignant glioma
Icodextrin 7.5% with Electrolytes Peritoneal Dialysis Solution | Extraneal (with 7.5% Icodextrin) Peritoneal [NAME] | Treatment of those patients having end stage renal disease and requiring peritoneal dialysis treatment.
nitazoxanide | Alinia | Treatment of intestinal giardiasis
Nitazoxanide | Alinia | Treatment of cryptosporidiosis.
Synthetic porcine secretin |  | For use in the evaluation of exocrine pancreas function.
Buprenorphine hydrochloride | Subutex | Treatment of opiate addiction in opiate users.
Buprenorphine in combination with naloxone | Suboxone | Treatment of opiate addiction in opiate users.
oxybate | Xyrem | Treatment of narcolepsy.
rasburicase | Elitek | Treatment of malignancy-associated or chemotherapy-induced hyperuricemia.
treprostinil | Remodulin | Treatment of pulmonary arterial hypertension.
Synthetic porcine secretin |  | For use in conjunction with diagnostic procedures for pancreatic disorders to increase pancreatic fluid secretion.
Synthetic porcine secretin |  | For use in the diagnosis of gastrinoma associated with [NAME] syndrome.
ibritumomab tiuxetan | [NAME] | Treatment of B-cell non-Hodgkin's lymphoma.
imatinib mesylate | [NAME] | Treatment of gastrointestinal  stromal tumors
Nitisinone | Orfadin | Treatment of tyrosinemia type 1.
Bosentan | Tracleer | Treatment of pulmonary arterial hypertension.
Topiramate | Topamax | Treatment of Lennox-Gastaut syndrome.
Zoledronate | [NAME], Zabel | Treatment of tumor induced hypercalcemia.
somatropin [rDNA] | Genotropin | Treatment of growth failure in children who were born small for gestational age.
Imatinib | [NAME] | Treatment of chronic myelogenous leukemia
[NAME] | Campath | Treatment of chronic lymphocytic leukemia.
Botulinum toxin type A | Botox | Treatment of cervical dystonia.
Botulinum toxin type B | Myobloc | Treatment of cervical dystonia.
Fomepizole | Antizole | Treatment of methanol or ethylene glycol poisoning.
Mitoxantrone | Novantrone | Treatment of secondary-progressive multiple sclerosis.
Mitoxantrone | Novantrone | Treatment of progressive-relapsing multiple sclerosis.
Antivenin, crotalidae polyvalent immune Fab (ovine) | CroFab | Treatment of envenomations inflicted by North American crotalid snakes.
Arsenic trioxide | Trisenox | Treatment of acute promyelocytic leukemia.
Somatropin [rDNA] | Genotropin | Treatment of short stature in patients with [NAME] syndrome.
Follitropin alfa, recombinant | Gonal-F | For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism.  AMENDED indication 6/27/00:  For the induction of spermatogenesis in men with pr
[NAME] zogamicin | Mylotarg | Treatment of CD33-positive acute myeloid leukemia.
Epoprostenol | Flolan | Treatment of secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease.
Interferon gamma-1b | Actimmune | Delaying time to disease progression in patients with severe, malignant osteopetrosis.
Bexarotene | Targretin | Treatment of cutaneous T-cell lymphoma.
Nitric oxide | INOmax | Treatment of persistent pulmonary hypertension in the newborn.
Levocarnitine | Carnitor | Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.
Exemestane | Aromasin | Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Caffeine | Cafcit | Treatment of apnea of prematurity.
Epirubicin | Ellence | Treatment of breast cancer.
Temozolomide | Temodar | Treatment of recurrent malignant glioma.
[NAME] liposome | Doxil | Treatment of ovarian cancer.
[NAME] | Ethyol | Reduction of the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
etanercept | Enbrel | Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.
Antihemophilic factor/[NAME] factor complex (human), dried, pasteurized | Humate-P | Treatment of patients with [NAME] disease
Cytarabine liposomal | DepoCyt | Treatment of neoplastic meningitis.
Coagulation factor VIIa (recombinant) | NovoSeven | Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor [NAME] or Factor IX.
Lidocaine patch 5% | Lidoderm Patch | For relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.
denileukin diftitox | Ontak | Treatment of patients with cutaneous T-cell lymphoma
Busulfan | Busulfex | As preparative therapy in the treatment of malignancies with bone marrow transplantation.
Alitretinoin | Panretin | Treatment of AIDS-related Kaposi's sarcoma.
Atovaquone | Mepron | Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients defined by a history of one or more episodes of PCP and/or a peripheral CD4+ (T4 helper/inducer) [NAME] less than or equal to 200/mm3.
Modafinil | Provigil | Treatment of excessive daytime sleepiness in narcolepsy.
Cytomegalovirus immune globulin (human) | CytoGam | Prevention or attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants.
Thyrotropin alpha | Thyrogen | As an adjunct in the diagnosis of thyroid cancer.
Octreotide | Sandostatin LAR | Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.
Octreotide | Sandostatin LAR | Treatment of acromegaly.
Octreotide | Sandostatin LAR | Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma).
Valrubicin | Valstar | Treatment of carcinoma in situ of the urinary bladder.
[NAME] | Remicade | Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapy; and treatment of patients with fistulizing Crohn's disease for the reduction in th
[NAME] | Lamictal | Treatment of Lennox-Gastaut syndrome.
Thalidomide | Thalomid | Treatment of erythema nodosum leprosum.
Rifapentine | Priftin | Treatment of pulmonary tuberculosis.
Mafenide acetate solution | Sulfamylon solution | For use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.
[NAME] | Simulect | Prophylaxis of solid organ rejection.
Sacrosidase | Sucraid | Treatment of congenital sucrase-isomaltase deficiency.
Filgrastim | Neupogen | Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia.
[NAME] | Refluden | Treatment of heparin-associated thrombocytopenia type II.
Hydroxyurea | [NAME] | Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.
Pilocarpine HCl | Salagen | Treatment of xerostomia and [NAME] in [NAME]'s syndrome patients.
Aldesleukin | Proleukin | Treatment of metastatic melanoma.
Sterile talc powder | Sclerosol Intrapleural Aerosol | Treatment of malignant pleural effusion.
Tobramycin for inhalation | TOBI | Treatment of bronchopulmonary infections of Pseudomonas aeruginosa in cystic fibrosis patients.
Somatropin for injection | Nutropin | As replacement therapy for growth hormone deficiency in adults after epiphyseal closure.
[NAME] | Zenapax | Prevention of acute renal allograft rejection.
Ursodiol | URSO | Treatment of patients with primary biliary cirrhosis.
Fomepizole | Antizole | Treatment of methanol or ethylene glycol poisoning.
rituximab | Rituxan | Treatment of [NAME] B-cell lymphoma.
Oprelvekin | Neumega | Prevention of severe chemotherapy-induced thrombocytopenia.
Somatropin | Genotropin | Treatment of adults with growth hormone deficiency.
Sermorelin acetate | Geref | Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.
Liposomal amphotericin B | AmBisome | Treatment of visceral leishmaniasis.
Liposomal amphotericin B | AmBisome | Treatment of cryptococcal meningitis.
Paclitaxel | Taxol | Treatment of AIDS-related Kaposi's sarcoma.
Diazepam viscous solution for rectal administration |  | For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity.
[NAME] | Fareston | Hormonal therapy of metastatic carcinoma of the breast.
Anagrelide | Agrylin | Treatment of essential thrombocythemia.
Coagulation Factor IX (recombinant) | BeneFix | Treatment of hemophilia B.
Zinc acetate | Galzin | Treatment of Wilson's disease.
Somatropin | Humatrope | Treatment of short stature associated with Turner syndrome.
Somatropin for injection | Nutropin | Treatment of short stature associated with Turner's syndrome.
Glatiramer acetate | Copaxone | Treatment of multiple sclerosis.
Mitoxantrone | Novantrone | Treatment of hormone refractory prostate cancer.
[NAME] | Cystadane | Treatment of homocystinuria.
Amphotericin B lipid complex | Abelcet | Treatment of invasive fungal infections.
Clonidine | Duraclon | For continous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to, or unresponsive to, intraspinal opiates.
Buffered intrathecal electrolyte/dextrose injection | Elliotts B Solution | For use as a diluent in the intrathecal administration of methotrexate and cytarabine for the prevention or treatment meningeal leukemia and lymphocytic lymphoma.
Pentosan polysulfate sodium | Elmiron | Treatment of interstitial cystitis.
polifeprosan 20 with carmustine | Gliadel | Treatment of malignant glioma.
Midodrine HCl | Amatine | Treatment of patients with symptomatic orthostatic hypotension.
Somatropin for injection | Serostim | Treatment of AIDS-associated catabolism/weight loss.
Fosphenytoin | Cerebyx | For the acute treatment of patients with status epilepticus of the grand mal type.
Albendazole | Albenza | Treatment of neurocysticercosis due to Taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocys
Albendazole | Albenza | Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).
Corticorelin ovine triflutate | [NAME] | For use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushings syndrome.
Ofloxacin | Ocuflox Ophthalmic Solution | Treatment of bacterial corneal ulcers.
Allopurinol sodium | Aloprim for Injection | Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy.
Interferon beta-1a | Avonex | Treatment of multiple sclerosis.
sodium phenylbutyrate | Buphenyl | Treatment of urea cycle disorders: carbamylphosphate synthetase deficiency, ornithine transcarbamylase deficiency, and arginiosuccinic acid synthetase deficiency.
Daunorubicin citrate liposome injection | DaunoXome | Treatment of patients with advanced HIV-associated Kaposi's sarcoma.
Ganciclovir intravitreal implant | [NAME] | Treatment of cytomegalovirus retinitis.
Bleomycin sulfate | Blenoxane | Treatment of malignant pleural effusion.
Respiratory syncytial virus immune globulin (Human) | Respigam | Prophylaxis of respiratory syncytial virus lower respiratory tract infections in infants and young children at high risk of RSV disease.
Filgrastim | Neupogen | For use in the mobilization of peripheral blood progenitor cells for collection in patients who will receive myeloablative or myelosuppressive chemotherapy.
Porfimer sodium | Photofrin | For the photodynamic therapy of patients with primary or recurrent obstructing (either partially or completely) esophageal carcinoma.
Riluzole | Rilutek | Treatment of amyotrophic lateral sclerosis.
[NAME] | Ethyol | For use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma.
Tretinoin | Vesanoid | Treatment of acute promyelocytic leukemia.
Interferon alfa-2a | Roferon A | Treatment of chronic myelogenous leukemia.
Epoprostenol | Flolan | Treatment of primary pulmonary hypertension.
Sargramostim | Leukine | To reduce neutropenia and leukopenia and decrease the incidence of death due to infection in patients with acute myelogenous leukemia.
Amiodarone HCl | Cordarone | For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.
[NAME] | Zinecard | For the prevention of cardiomyopathy associated with doxorubicin administration.
Rho (D) immune globulin intravenous (human) | WinRho SD | Treatment of immune thrombocytopenic purpura.
Filgrastim | Neupogen | Treatment of patients with severe chronic neutropenia (absolute neutrophil count less than 500/mm3).
Cysteamine | Cystagon | Treatment of nephropathic cystinosis.
Sulfadiazine |  | For use in combination with pyrimethamine for the treatment of Toxoplasma gondii encephalitis in patients with and without AIDS.
Aminosalicylic acid | Paser [NAME] | Treatment of tuberculosis infections
Filgrastim | Neupogen | Treatment of neutropenia associated with bone marrow transplants.
Rifampin, isoniazid, pyrazinamide | Rifater | For the short-course treatment of tuberculosis.
Imiglucerase | Cerezyme | Replacement therapy in patients with types I, II, and III Gaucher's disease.
Pilocarpine | Salagen | Treatment of xerostomia induced by radiation therapy for head and neck cancer.
Desmopressin acetate |  | Treatment of mild hemophilia A and [NAME] disease.
Pegaspargase | [NAME] | Treatment of acute lymphocytic leukemia.
Dornase alfa | Pulmozyme | To reduce mucous viscosity and enable the clearance of airway secretions in patients with cystic fibrosis.
Aprotinin | Trasylol | For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c
Immune globulin intravenous, human | Gamimune N | Infection prophylaxis in pediatric patients affected with the human immunodeficiency virus.
Trimetrexate glucuronate | [NAME] | Treatment of Pneumocystis carinii pneumonia in AIDS patients.
Somatropin for injection | Nutropin | Treatment of growth retardation associated with chronic renal failure.
Lodoxamide tromethamine | Alomide Ophthalmic Solution | Treatment of vernal keratoconjunctivitis.
Megestrol acetate | Megace | Treatment of patients with anorexia, cachexia, or significant weight loss (=/>10% of baseline body weight) and confirmed diagnosis of AIDS.
Felbamate | Felbatol | Treatment of Lennox-Gastaut syndrome.
Interferon beta-1b | Betaseron | Treatment of multiple sclerosis.
Levomethadyl acetate hydrochloride | Orlaam | Treatment of heroin addicts suitable for maintenance on opiate agonists.
Leuprolide acetate | [NAME] | Treatment of central precocious puberty.
Cladribine | [NAME] | Treatment of hairy cell leukemia.
Antihemophilic factor (recombinant) | Kogenate | Prophylaxis and treatment of bleeding in individuals with hemophilia A or for prophylaxis when surgery is required in individuals with hemophilia A.
[NAME] pendetide | [NAME] | Detection of ovarian carcinoma.
Rifabutin | Mycobutin | Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection.
[NAME] | [NAME] | For the stimulation of appetite and prevention of weight loss in patients with a confirmed diagnosis of AIDS.
Levocarnitine | Carnitor | Treatment of primary and secondary carnitine deficiency of genetic origin.
Atovaquone | Mepron | Treatment of AIDS associated Pneumocystis [NAME].
Melphalan | Alkeran For Injection | Treatment of patients with multiple myeloma for whom oral therapy is inappropriate.
Sotalol HCl | Betapace | Treatment of life-threatening ventricular tachyarrhythmias.
Coagulation factor IX | Mononine | Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B.
Halofantrine | Halfan | Treatment of mild to moderate acute malaria caused by susceptible strains of P. falciparum and P. vivax.
Teniposide | [NAME] for injection | Treatment of refractory childhood acute lymphocytic leukemia.
Baclofen | [NAME] | Treatment of intractable spasticity caused by spinal cord injury, multiple sclerosis, and other spinal diseases (including spinal ischemia, spinal tumor, transverse myelitis, cervical spondylosis, and degenerative myelopathy).
Zalcitabine | [NAME] | Treatment of AIDS.
Aldesleukin | Proleukin | Treatment of metastatic renal cell carcinoma.
Nafarelin acetate | [NAME] | Treatment of central precocious puberty.
Liothyronine sodium injection | Triostat | Treatment of myxedema coma/precoma.
[NAME] (human) | Thrombate III | For replacement therapy in congenital deficiency of AT-III for prevention and treatment of thrombosis and pulmonary emboli.
Histrelin acetate | [NAME] | Treatment of central precocious puberty.
Leucovorin | Leucovorin calcium | For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.
[NAME] for injection | Nipent | Treatment of hairy cell leukemia.
[NAME] sulfate concentrate (preservative free) | Infumorph | For use in microinfusion devices for intraspinal administration in the treatment of intractable chronic pain.
Beractant | [NAME] intratracheal suspension | Prevention of neonatal respiratory distress syndrome.
Beractant | [NAME] intratracheal suspension | Treatment of neonatal respiratory distress syndrome.
Fludarabine phosphate | Fludara | Treatment of chronic lymphocytic leukemia (CLL), including refractory CLL.
Alglucerase injection | Ceredase | For replacement therapy in patients with [NAME]'s disease type I.
Sargramostim | Leukine | Treatment of neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment.
Gallium nitrate injection | Ganite | Treatment of hypercalcemia of malignancy.
Coagulation Factor IX (human) | AlphaNine | For use as replacement therapy in patients with hemophilia B for the prevention and control of bleeding episodes, and during surgery to correct defective hemostasis.
Epoetin alfa | Epogen | Treatment of anemia associated with HIV infection or HIV treatment.
[NAME] | Hexalen | Treatment of advanced adenocarcinoma of the ovary.
Interferon gamma 1-b | Actimmune | Treatment of chronic granulomatous disease.
Calcium acetate | Phos-Lo | Treatment of hyperphosphatemia in end stage renal failure.
Eflornithine HCl | Ornidyl | Treatment of Trypanosoma brucei gambiense infection (sleeping sickness).
Citric acid, glucono-delta-lactone and magnesium carbonate | Renacidin Irrigation | Treatment of renal and bladder calculi of the apatite or struvite variety.
Idarubicin HCl for injection | Idamycin | Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
Colfosceril palmitate, cetyl alcohol, tyloxapol | Exosurf Neonatal for Intratracheal Suspension | Treatment of established hyaline membrane disease at all gestational ages.
Colfosceril palmitate, cetyl alcohol, tyloxapol | Exosurf Neonatal for Intratracheal Suspension | Prevention of hyaline membrane disease, also known as respiratory distress syndrome, in infants born at 32 weeks gestation or less.
Iobenguane Sulfate I 131 |  | For use as a diagnostic adjunct in patients with pheochromocytoma.
Pegademase bovine | Adagen | For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency.
Botulinum toxin type A | Botox | Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above).
Botulinum toxin type A | Botox | Treatment of blepharospasm associated with dystonia in adults (patients 12 years of age and above).
Cromolyn sodium | Gastrocrom | Treatment of mastocytosis.
[NAME] (human) | ATnativ | For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism.
Gonadorelin acetate | Lutrepulse | For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous [NAME] secretion.
Ganciclovir sodium | Cytovene | Treatment of cytomegalovirus retinitis in immunocompromised patients with AIDS.
Pentamidine isethionate | Nebupent | Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.
Selegiline HCl | Eldepryl | As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.
Epoetin alfa | Epogen | Treatment of anemia associated with end stage renal disease.
Rifampin | Rifadin I.V. | For antituberculosis treatment where use of the oral form of the drug is not feasible.
Mefloquine HCl | [NAME] | Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs.
Mefloquine HCl | [NAME] | Treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax.
Ifosfamide | [NAME] | Treatment of testicular cancer.
Mesna | Mesnex | For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.
Ethanolamine oleate | Ethamolin | Treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.
Succimer | Chemet capsules | Treatment of lead poisoning in children.
Metronidazole (topical) | [NAME] | Treatment of acne rosacea.
Interferon alfa-2a (recombinant) | Roferon-A | Treatment of AIDS related Kaposi's sarcoma.
Interferon alfa-2b (recombinant) | Intron A | Treatment of AIDS-related Kaposi's sarcoma.
Leucovorin | Leucovorin calcium | For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.
Tiopronin | Thiola | Prevention of cystine nephrolithiasis in patients with homozygous cystinuria.
Methotrexate sodium | Methotrexate | Treatment of osteogenic sarcoma.
Benzoate and phenylacetate | Ucephan | For adjunctive therapy in the prevention and treatment of hyperammonemia in patients with urea cycle enzymopathy due to carbamylphosphate synthetase, ornithine, transcarbamylase, or argininosuccinate synthetase deficiency.
Mitoxantrone HCl | Novantrone | Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
Teriparatide | [NAME] | Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.
[NAME] (human) | [NAME] | For replacement therapy in the alpha-1-proteinase inhibitor congenital deficiency state.
Pentastarch | Pentaspan | As an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means.
Etidronate disodium | Didronel | Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration.
[NAME] | Retrovir | Treatment of AIDS.
[NAME] | Retrovir | Treatment of AIDS related complex.
Somatropin for injection | Humatrope | For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.
Tranexamic acid | Cyklokapron | Treatment of patients with congenital coagulopathies who are undergoing surgical procedures (e.g. dental extractions).
Clofazimine | Lamprene | Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.
Calcitonin-human for injection | Cibacalcin | Treatment of symptomatic Paget's disease (osteitis deformans).
Urofollitropin | Metrodin | For induction of ovulation in patients with polycystic ovarian disease who have an elevated LH/FSH ratio and who have failed to respond to adequate clomiphene citrate therapy.
Digoxin immune FAB (Ovine) | Digibind | Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy.
Levocarnitine | Carnitor | Treatment of genetic carnitine deficiency.
Trientine HCl | Syprine | Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine.
Monooctanoin | Moctanin | For dissolution of cholesterol gallstones retained in the common bile duct.
[NAME] for injection | Protropin | For long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
Somatropin | Nutropin | For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
Potassium citrate | Urocit-K | For avoidance of the complication of calcium stone formation in patients with uric lithiasis.
Potassium citrate | Urocit-K | Prevention of calcium renal stones in patients with hypocitraturia.
Potassium citrate | Urocit-K | Prevention of uric acid nephrolithiasis.
Naltrexone HCl | Trexan | For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals.
Pentamidine isethionate | Pentam 300 | Treatment of Pneumocystis carinii pneumonia.
Cromolyn sodium 4% ophthalmic solution | Opticrom 4% ophthalmic solution | Treatment of vernal keratoconjunctivitis.
Chenodiol | Chenix | For patients with radiolucent stones in well opacifying gallbladders, in whom elective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age.
Hemin | Panhematin | Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.
(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid |  | Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy
(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol |  | Treatment of Stage IIB through Stage IV malignant melanoma
(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol |  | Treatment of pancreatic cancer
(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol |  | Treatment of cholangiocarcinoma
(1R,2R)-Octanoic acid [2-(2',3'-dihydrobenzo[1,4]dioxin-6'-yl)-2-hydroxy-l-pyrrolidin-1-ylmethyl-ethyl]-amide-L-tartaric acid salt |  | Treatment of Gaucher disease
(1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol |  | Treatment of pulmonary tuberculosis (active disease)
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride |  | Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride |  | Treatment of acute lymphoblastic leukemia
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride |  | Treatment of T-cell non-Hodgkin's lymphoma
(2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide | FK778 | Prevention of acute rejection following kidney, heart, and liver tranplantation
(3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine |  | Treatment of tuberculosis.
(3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid |  | Treatment of patients undergoing solid organ transplantation.
(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime | Gimatecan | Treatment  malignant glioma
(6R,S)5,10-methylene-tetrahydrofolic acid | CoFactor | For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer
(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid |  | Prevention of post-operative complications of aortic anuerysm surgical repair
(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole |  | Treatment of pulmonary tuberculosis.
(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride |  | Treatment of small cell lung cancer
(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride |  | Treatment of multiple myeloma
(R)-4-(3-morpholin-4-yl-l-phenylsulfanylmenthyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-l-enylmethyl]-piperazin-l-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride |  | Treatment of chronic lymphocytic leukemia
(R)-N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide |  | Treatment of circadian rhythm sleep disorders in blind people with no light perception
(R)-N-[2-(6-Chloro-methoxy-1H-indol-3yl)propyl]acetamide |  | Treatment of neuroleptic-induced tardive dyskinesia in schizophrenia patients
(s)-3'-(HO)-DADFT-PE |  | Treatment of chronic iron overload in patients with transfusion-dependent anemias
(UDU-stereoisomer of c-UJUun UNU-terminal UkUnhibitor) |  | Treatment of acute sensorineural hearing loss
(Z-8-methyl-N-vanillyl-6-nonnamide) ; Civamide |  | Treatment of postherpetic neuralgia.
[131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide |  | Treatment of metastatic melanoma, stages IIB, IIC, III and IV
[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride |  | Treatment of Amyotrophic Lateral Sclerosis
[Lu-177]-DOTA-Tyr3-Octreotate |  | Treatment of gastro-entero-pancreatic neuroendocrine tumors
[Nle4, D-Phe7]-a-melanocyte stimulating hormone |  | Treatment of erythropoietic porphyrias
1,5-(Butylimino)-1,5 dideoxy,D-glucitol |  | Treatment of Fabry's disease.
11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.12,6.18,12}heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene |  | For treatment of myeloproliferative disorders (MPD) with the JAK2 V617F mutation.
111Indium pentetreotide | SomatoTher | Treatment of somatostatin receptor positive neuroendocrine tumors.
166Ho-DOTMP |  | Treatment of multiple myeloma.
17 a-Hydroxyprogesterone caproate | Gestiva | Prevention of preterm birth in singleton pregnancies
17-allylamino-17-demethoxygeldanamycin (17-AGG) |  | For the treatment of chronic myelogenous leukemia.
1-Deoxygalactonojirimycin |  | Treatment of Fabry Disease
1-dexynojirimycin hydrochloride |  | Treatment of Pompe disease
2 dimethylbutyrate |  | Treatment of beta thalassemia
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine [NAME]) tartrate salt |  | Treatment of multiple myeloma.
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine [NAME]) tartrate salt |  | Treatment of ovarian carcinoma
2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylic acid |  | Treatment of familial amyloid polyneuropathy
2-(3-diethylaminopropyl)-8,8-dipropyl-2-azaspiro [4,5] decan dimaleate | [NAME] | Treatment of mulitple myeloma and associated bone resorption
2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate | [NAME] | Treatment of carcinoid tumors
2',3',5'-tri-o-acetyluridine |  | Treatment of mitochondrial disease
2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, monohydrate, (6R)-; (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate |  | Treatment of amyothrophic lateral sclerosis (ALS).
2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole | PreVonco (tm) | Treatment of hepatocellular carcinoma.
2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide |  | Treatment of malignant melanoma stages IIb through IV.
2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide |  | Treatment glioblastoma multiforme when used in combination with DNA-damaging agents
2-0-Butyryl-1-0-octyl-myo-inositol 3,4,5,6-tetrakisphosphate |  | Treatment of cystic fibrosis
2-0-desulfated heparin | Aeropin | Treatment of cystic fibrosis.
20-mer complementary to [NAME] |  | Treatment of stomach cancer
20-mer oligonucleotide complementary to [NAME] |  | Treatment of pancreatic cancer
20-mer oligonucleotide complementary to [NAME] |  | Treatment of glioblastoma
20-mer oligonucleotide complementary to [NAME] |  | Treatment of renal cell carcinoma
20-mer oligonucleotide complementary to [NAME] |  | Treatment of ovarian cancer
2'-3'-dideoxyadenosine |  | Treatment of aquired immunodeficiency syndrome.
24,25 dihydroxycholecalciferol |  | Treatment of uremic osteodystrophy.
2-chloroethyl-3-sarcosinamide-1-nitrosourea |  | Treatment for malignant gliomas
2-chloroethyl-3-sarcosinamide-1-nitrosourea | Sarmustine | Treatment for malignant glioma
2'-deoxycytidine |  | As a host-protective agent in the treatment of acute myelogenous leukemia.
2-iminobiotin |  | Treatment of perinatal asphyxia.
2-methoxyestradiol | PulmoLAR | Treatment of pulmonary arterial hypertension
2-methoxyestradiol | Panzem NCD | Treatment of ovarian cancer
2-methoxyestradiol | Panzem | Treatment of multiforme glioblastoma
2-methoxyestradiol | Panzem | Treatment of multiple myeloma
2'-O-methyl-phosphorothiolate oliogribonucleotide |  | Treatment of [NAME] muscular dystrophy
3-(3,5-Dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one |  | Treatment of von Hippel-Lindau disease.
3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one |  | Treatment of Kaposi's sarcoma.
3,4-diaminopyridine |  | Treatment of Lambert-Eaton myasthenic syndrome.
3,5,3'-triiodothyroacetate |  | Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland.
3-[5-(2-fluoro-plhenyl)-[1,2,4]oxadiazole-3-yl]benzoic acid |  | Treatment of Muscular Dystrophy resulting from premature stop mutations in the dystrohin gene
3-[5-(2-fluoro-plhenyl)-[1,2,4]oxadiazole-3-yl]benzoic acid |  | For use in the treatment of cystic fibrosis resulting fron a nonsense (premature stopcodon) mutation in the cystic bibrosis transmembrane conductance regulatory gene.
3-[5-(2-fluoro-plhenyl)-[1,2,4]oxadiazole-3-yl]benzoic acid |  | Treatment of spinal muscular atrophy.
3'-azido-2',3'dideoxyuridine | AZDU | Treatment of acquired immunodeficiency syndrome.
3-fluoro-5-[5-(2-menthyl-thiazol-4-ylethylnyl)-pyridin-2-yl]-benzonitrile dihydrochloride |  | Treatment of behavioral abnormalities associated with fragile X syndrome.
4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl) |  | Treatment of Chronic Functional Vomiting to include functional vomiting and cyclic vomiting syndrome.
4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl |  | Treatment of Huntington disease.
4, 5 dibromorhodamine methyl ester | Theralux Photodynamic Therapy | Treatment of follicular lymphoma
4, 5 dibromorhodamine methyl ester | Theralux Photodynamic Therapy | Treatment of diffuse large B-cell lymphoma
4,5 dibromorhodamine methyl ester | Theralux Photodynamic Therapy | For immune reconstitution and prevention of graft versus host disease following allogeneic hematopoietic stem cell transplantation.
4,5-dibromorhodamine 123 | Theralux Irradiation Device | Treatment of chronic myelogenous leukemia
4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo b,e][1,4]diazepin-11-one |  | Treatment of malignanat glioma
4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl] tetrahydro-N-hydroxy-2H-pyran-4-carboxamide |  | Prophylaxis of organ rejection in patients receiving allogeneic liver transplants
4-[1]benzofuro[3,2-d]pyrimidin-4-yl-N-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbothioamide |  | Treatment, in combination with radiotherapy and temozolomide chemotherapy, of patients with glioblastoma multiforme.
40SD02 |  | Treatment of chronic iron overload resulting from conventional transfusional treatment of beta-thalassemia major and sickle cell anemia.
4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-arabinofuranosyl]-2(1H)-pyrimidinone |  | Treatment of hepatocellular carcinoma.
4-Aminopyridine |  | Treatment chronic functional motor and sensory deficits from [NAME] syndrome
4-aminosalicylic acid | Paser [NAME] | Treatment of acute flares in pediatric patients with ileo-cecal Crohn's disease
4-aminosalicylic acid | Pamisyl (P-D), [NAME] (Squibb) | Treatment of mild to moderate ulcerative colitis in patients intolerant to sulfasalazine.
4-cholest-en-3-one, oxime |  | Treatment of amyotrophic lateral sclerosis
4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide monohydrochloride |  | Treatment of acute myeloid leukemia
4-trifluoromethyl-N-(3.3a.4.4a.5,5a,6,6a-octahydro-1,3-dioxo-4,6ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide |  | Treatment of smallpox.
4-trifluoromethyl-N-(3.3a.4.4a.5,5a,6,6a-octahydro-1,3-dioxo-4,6ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide |  | post exposure prophylaxis against smallpox
5(S)-(2'-hydroxy ethoxy)-20(S)-Camptothecin |  | Treatment of osteosarcoma (bone cancer)
5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI) |  | Treatment of malignant gliomas
5,5',5"-[Phosphinothioylidyne-tris(imino-2,1-ethanediyl)]tris[5-methylchelidoninium]trihydroide hexahydrochloride |  | Treatment of pancreatic cancer
5,6-dihydro-5-azacytidine |  | Treatment of malignant mesothelioma.
5,7-dihydroxy-3-(4-hydroxyphenyl)-chromen-4-one |  | Prevention of acute radiation syndrome
5-[(E)-2-(4-hydroxyphenyl)-ethenyl] [NAME] diol | Resveratrol | Treatment of MELAS syndrome
506U78 |  | Treatment of chronic lymphocytic leukemia.
5a8, monoclonal antibody to CD4 |  | For use in post-exposure prophylaxis for occupational exposure to human immunodeficiency virus.
5-aza-2'-deoxycytidine |  | Treatment of acute leukemia.
5-Azacitidine | Vidaza | Treatment of acute myeloid leukemia
5-hydroxymethyl-2-furfuraldehyde |  | Treatment of sickle cell disease
5-iodo-2-pytimidinone-2'-deoxyribose |  | Treatment of malginant glioma
5-methyl-1-phenyl-2-(1H)-pyridone(CAS 53179-13-8) | Pirfenidone | Treatment of idiopathic pulmonary fibrosis
5'-O-(trans-9''-octadecenoyl)-1-B-D-arabinofuranosyl cytosine |  | Treatment of acute myeloid leukemia.
6 alpha-ethylchenodeoxycholic acid |  | Treatment of primary biliary cirrhosis
6,8-bis-benzylsulfanyl-octanoic acid |  | Treatment of pancreatic cancer
6-alpha-ethylchenodeoxycholic acid |  | Treatment of primary sclerosing cholangitis
6-hydroxymethylacylfulvene |  | Treatment of histologically confirmed advanced or metastatic pancreatic cancer.
8-methoxsalen | Uvadex | For use in conjunction with the UVAR photopheresis to treat diffuse systemic sclerosis.
8-methoxsalen | Uvadex | For the prevention of acute rejection of cardiac allografts.
90Y-hPAMA4 | PAN-Cide | Treatment of pancreatic cancer
9-cis-retinoic acid |  | Prevention of retinal detachment due to proliferative vitreoretinopathy.
9-nitro-20-(S)-camptothecin |  | Treatment of pancreatic cancer.
9-nitro-20-(S)-camptothecin | Camvirex | Treatment of pediatric HIV infection/AIDS
a-(3-aminophthalimido) glutaramide | Actimid | Treatment of multiple myeloma
A10 & AS2-1 Antineoplaston |  | Treatment for patients with brain stem glioma
[NAME] |  | Treatment of Leber congenital amaurosis due to RPE65 mutations.
[NAME] |  | Treatment of lupus nephritis.
ACA125 |  | Treatment of epithelial ovarian cancer
Acetylcysteine | Mucomyst/Mucomyst 10 IV | Intravenous treatment of patients presenting with moderate to severe acetaminophen overdose.
Acid sphingomyelinase |  | Treatment of acid sphingomyelinase deficiency (Niemann-Pick disease).
Adalimumab | Humira | Treatment of pediatric Crohn's disease.
Adeno-associated vector expressing the human lipoprotein lipase protein |  | Treatment of lipoprotein lipase deficiency
Adeno-associated viral vector containing the gene for human coagulation factor IX | Coagulin-B | Intramuscular treatment of patients with moderate to severe hemophilia
Adeno-associated viral vector containing the gene for human coagulation factor IX | Coagulin-B | Intrahepatic treatment of patients with moderate to severe hemophilia
Adeno-associated viral vector expressing human acid alpha glucosidase gene |  | Treatment of Pompe disease
adeno-associated viral vector expressing human retinoschisin-1 gene |  | Treatment of X-linked juvenile retinoschisis (XLRS).
Adeno-associated viral vector serotype 5 containing human ABCA4 gene |  | Treatment of [NAME]'s disease.
Adeno-associated viral-based vector cystic fibrosis gene therapy |  | Treatment of cystic fibrosis.
Adenosine |  | For use in conjunction with [NAME] in the treatment of brain tumors.
Adenoviral vector expressing Herpes simplex virus thymidine kinase gene |  | Treatment of malignant brain tumors
Adenovirus-based vector Factor [NAME] complementary DNA to somatic cells | MiniAdFVIII | Treatment of hemophilia A.
adenovirus-mediated herpes [NAME] kinase gene |  | Use with gancyclovir in the treatment of malignant glioma
Aerosolized pooled immune globulin |  | Treatment of respiratory syncytial virus lower respiratory tract disease.
a-Galactosidase A | Plant-Produced Human a-Glactosidase A | Treatment of Fabry's disease
Aglycosyl anti-CD3 monoclonal antibody |  | Treatment of new-onset type I diabetes mellitus
AI-RSA |  | Treatment of autoimmune uveitis.
Albuterol |  | Prevention of  paralysis due to spinal cord injury
ALD-101 |  | To improve patient outcomes by decreasing time to platlet and neutrophil engraftment in patients with inherited metabolic diseases (IMD) undergoing umbilical cord blood transplantation.
Aldesleukin | Proleukin | Treatment of primary immunodeficiency disease associated with T-cell defects.
Aldesleukin | Proleukin | Treatment of acute myelogenous leukemia.
Aldesleukin | Proleukin | For the treatment non-Hodgkin's lymphoma.
Alefacept | Amevive | For use as prophylaxis of rejection in patients receiving allogenic solid organ transplants.
alendronate | Fosamax | Treatment of osteogenesis imperfecta in pediatric patients 4 years of age and older
Alendronate disodium | Fosamax | Treatment of the bone manifestations of Gaucher disease
[NAME] |  | Management of postherpetic neuralgia
[NAME] |  | Treatment of painful HIV-associated neuropathy
Alglucerase injection | Ceredase | Replacement therapy in patients with Type II and III Gaucher's disease.
alicaforsen |  | Treatment of pouchitis.
Alitretinoin | Panretin | Treatment of acute promyelocytic leukemia
allantoin | Alwextin | Treatment of skin blistering and erosions associated with inherited epidermolysis bullosa
Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix | [NAME] (r) | Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis
Allogeneic human retinal pigment epithelial cells on gelatin microcarriers | Spheramine | Treatment of Hoehn and [NAME] stage 3 and 4 Parkinson's disease.
allogeneic mesenchymal precursor cells derived from ex vivo healthy donors harvested from iliac crest. |  | Treatment of insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy.
Allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed lymphocyte culture | CYTOIMPLANT | Treatment of pancreatic cancer
Allogeneic retinal epithelial cells transfected with plasmid vector expressing ciliary neurotrophic growth factor |  | Treatment of retinitis pigmentosa
Allogeneic T-cells cultured with anti-CD3 and IL-2; transduced with retroviral vector (SFCMM-3), expressing herpes simplex 1 virus-thymidine kinase (HSV-TK) and truncated low affinity nerve growth factor receptor; selected with anti-low affinity nerve gro |  | Immunotherapy for acceleration of T-cell reconstitution in patients undergoing allogeneic hematopoietic stem cell transplantation
Allopurinol riboside |  | Treatment of cutaneous and visceral leishmaniasis.
Allopurinol riboside |  | Treatment of Chagas' disease.
Allopurinol sodium |  | Ex-vivo preservation of cadaveric kidneys for transplantation
Alpha-1-acid glycoprotein |  | Treatment of cocaine overdose
Alpha-1-acid glycoprotein |  | Treatment of tricyclic antidepressant poisoning
Alpha-1-antitrypsin (recombinant DNA Origin) |  | As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population.
Alpha1-antitrypsin(human) |  | Treatment of bronchiectasis
Alpha1-Proteinase Inhibitor (Human) |  | Inhalation therapy for the the treatment of congential deficiency of [NAME]-proteinase inhibitor.
Alpha1-Proteinase Inhibitor (Human) | ARC-API | Treatment of cystic fibrosis
alpha1-proteinase inhibitor (human) |  | Treatment of cystic fibrosis
[NAME] (human) |  | For slowing the progression of emphysema in alpha1-antitrypsin deficient patients.
Alpha-galactosidase A | Fabrase | Treatment of Fabry's disease.
Alpha-galactosidase A | CC-galactosidase | Treatment of alpha-galactosidase A deficiency ([NAME]'s disease).
Alpha-galactosidase A | Replagal | Long-term enzyme replacement therapy for the treatment of [NAME] disease.
Alpha-melanocyte stimulating hormone |  | Prevention and treatment of intrinsic acute renal failure due to ischemia.
Alpha-tocopherol quinone |  | Treatment of inherited mitochondrial respiratory chain diseases
Alprostadil |  | Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.
alteplase | Activase | Treatment of intraventricular hemmorage associated with intracerebral hemmorrhage
Alvocidib |  | Teatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.
ALX-0081 nanobody, directed towards the human A1 domain of [NAME] factor |  | Treatment of thrombotic thrombocytopenic purpura
AMG 531 |  | Treatment of thrombocytopenia associated with myelodysplasia syndrome
[NAME] | Ethyol | Treatment of myelodysplastic syndromes.
[NAME] | Ethyol | For use as a chemoprotective agent for cisplatin in the treatment of metastatic melanoma.
[NAME] | Ethyol | For use as a chemoprotective agent for cyclophosphamide in the treatment of advanced ovarian carcinoma.
[NAME] | Ethyol | For the reduction of the incidence and severity of toxicities associated with cisplatin administration.
Amikacin | SLIT  Amikacin | Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients
Amiloride HCl solution for inhalation |  | Treatment of cystic fibrosis.
Aminocaproic acid | Caprogel | For the topical treatment of traumatic hyphema of the eye.
Aminolevulinic acid hydrochloride | [NAME] | Treatment of esophageal dysplasia
Aminosalicylate sodium |  | Treatment of Crohn's disease.
Aminosidine | Paromomycin | Treatment of visceral leishmaniasis
Aminosidine | Paromomycin | Treatment of visceral leishmaniasis (kala-azar).
Aminosidine | Gabbromicina | Treatment of tuberculosis.
Aminosidine | Gabbromicina | Treatment of Mycobacterium avium complex.
Amiodarone | Amio-Aqueous | Treatment of incessant ventricular tachycardia.
ammonium tetrathiomolybdate |  | Treatment of idiopathic pulmonary fibrosis
Ammonium tetrathiomolybdate | Coprexa | Treatment of Wilson's disease.
Amonafide L-malate | Xanafide | Treatment of acute myeloid leukemia
Amphotericin B inhalation powder |  | Prevention of pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy including those receiving organ or stem cell transplants, or teated with chemotherapy or radiation for hematologic malignancies
Amphotericin B lipid complex | Abelcet | Treatment of invasive protothecosis.
Amphotericin B lipid complex | Abelcet | Treatment of invasive sporotrichosis.
Amphotericin B lipid complex | Abelcet | Treatment of invasive coccidioidomycosis.
Amphotericin B lipid complex | Abelcet | Treatment of invasive zygomycosis.
Amphotericin B lipid complex | Abelcet | Treatment of invasive candidiasis.
amrubicin |  | Treatment of small cell lung cancer
Amsacrine | Amsidyl | Treatment of acute adult leukemia.
Amyl nitrite, sodium nitrite, sodium thiosulfate | Cyanide [NAME] | Treatment of cyanide poisoning
Anagrelide | Agrylin | Treatment of thrombocytosis in chronic myelogenous leukemia.
Anagrelide | Agrylin | Treatment of polycythemia vera.
Ananain, comosain | Vianain | For the enzymatic debridement of severe burns.
Anaritide acetate | Auriculin | Treatment of patients with acute renal failure.
Anaritide acetate | Auriculin | Improvement of early renal allograft function following renal transplantation.
Anatibant |  | Treatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome
[NAME] | Viprinex | To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass.
[NAME] | MARstem | Treatment of myelodysplastic syndrome
[NAME] |  | Treatment of neutropenia associated with autologous bone marrow transplantation.
anthrax immune globulin (human) |  | Treatment of toxemia associated with inhalational anthrax.
anti human [NAME]-A human monoclonal antibody |  | Treatment of acute spinal cord injury
Anti pan T lymphocyte monoclonal antibody | Anti-t Lymphocyte Immunotoxin Xmmly-h65-rta | For ex-vivo treatment to eliminate mature T cells from potential bone marrow grafts.
Anti pan T lymphocyte monoclonal antibody | Anti-t Lymphocyte Immunotoxin Xmmly-h65-rta | For in-vivo treatment of bone marrow recipients to prevent graft rejection and graft versus host disease.
antiangiogenic components extracted from marine cartilage | [NAME] (AE-941) | Treatment of renal cell carcinoma
anti-CD23 IgG1, kappa monoclonal antibody |  | Treatment of chronic lymphocytic leukemia
anti-CD30 Fc engineered humanized monoclonal antibody |  | Treatment of Hodgkin lymphoma
Anti-CD40 mAb |  | Treatment of chronic lymphocytic leukemia
Anti-CD45 monoclonal antibodies |  | Prevention of acute graft rejection of human organ transplants.
Anti-CEA Sheep-human chimeric monoclonal antibody labeled w/iodine-131 (KAb201) |  | Treatment of pancreatic cancer
Anti-cytomegalovirus monoclonal antibodies |  | Prevention of human cytomegalovirus infection in bone marrow and organ transplant patients.
Anti-cytomegalovirus monoclonal antibodies |  | Treatment of human cytomegalovirus infection in bone marrow and organ transplant patients.
Anti-cytomegalovirus monoclonal antibodies |  | Prevention of human cytomegalovirus infection in patients diagnosed with AIDS.
Anti-cytomegalovirus monoclonal antibodies |  | Treatment of human cytomegalovirus infection in patients diagnosed with AIDS.
Anti-cytotoxic T lymphocyte antigen 4 monoclonal antibody |  | Treatment of stage IIb to stage IV metastatic melanoma
Antiepilepsirine |  | Treatment of drug resistant generalized tonic-clonic epilepsy in children and adults.
Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent | Kogenate(r) FS | Treatment of hemophilia A
anti-interferon-gamma Fab from goats |  | For the treatment of immunologic corneal allograft rejection
Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Antimelanoma Antibody XMMME-001-DTPA 111 Indium | Diagnostic use in imaging systemic and nodal melanoma metastasis.
Antimelanoma Antibody XMMME-001-RTA | Antimelanoma Antibody XMMME-001-RTA | Treatment of stage III melanoma not amenable to surgical resection.
antineoplaston A10, antineoplaston [NAME] |  | Treatment of gliomas
[NAME] |  | For use as an index of hepatic drug-metabolizing capacity.
Antisense 20-mer oligonucleotide complementary to R2 component of ribonucleotide reductase mRNA |  | Treatment of acute myeloid leukemia
antisense 20-mer phosphorothioate oligonucleotide [complementary to the coding region of R2 component of the human ribonucleotide reductase mRNA] | GTI-2040 | Treatment for renal cell carcinoma
Antisense inhibitor of apoB-100 |  | Treatment of homozygous familial hypercholesterolemia
Antisense oligonucleotide directed against connexin43 | Nexagon | Treatment of persistent corneal epithelial defects
Anti-T cell receptor murine monoclonal antibody |  | Prophylaxis of acute rejection of solid organ transplantation
Anti-tap-72 immunotoxin | Xomazyme-791 | Treatment of metastatic colorectal adenocarcinoma.
Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131 | Neuradiab | Treatment of primary malignant brain tumors
[NAME] (human) concentrate IV | [NAME] | For prophylaxis and treatment of thromboembolic episodes in patients with genetic AT-III deficiency.
[NAME] human | [NAME] human | Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition.
Anti-thymocyte Globulin (Rabbitt) | Thymoglobulin | Treatment of myelodysplastic syndrome (MDS)
Anti-thymocyte serum | Nashville Rabbit Anti-thymocyte Serum | Treatment of allograft rejection, including solid organ (kidney, liver, heart, lung, and pancreas) and bone marrow transplantation.
anti-T-lymphocyte immune globulin, rabbit |  | Prophylaxis of acute allograft rejection in adult recipients in solid organ transplantation.
Antivenin crotaline (pit-viper) equine immune F(ab)2) | Antivipmyn | Treatment of envenomation by Crotaline snakes
[NAME] (crotalidae) purified (avian) |  | Treatment of envenomation by poisonous snakes belonging to the [NAME] family.
Anti-von Willebrand Aptamer |  | Treatment of thrombotic thrombocytopenic purpura
AP1903 |  | Treatment of acute graft-versus-host disease in patients undergoing bone marrow transplantation.
APL 400-020 V-Beta DNA vaccine |  | Treatment of cutaneous T cell lymphoma.
Apomorphine |  | For use as rescue treatment for early morning motor dysfunction in late-stage Parkinson's disease.
Apomorphine |  | Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.
Apomorphine hydrochloride |  | For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous)
[NAME] (4-aminoquinoline analog) |  | Treatment of malaria
[NAME] | 99m Tc-labeled CEA-Scan | Diagnosis and localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma.
[NAME] |  | Treatment of malignant plueral mesothelioma
Arginine butyrate |  | Treatment of sickle cell disease and beta thalassemia.
Arginine butyrate |  | Treatment of beta-hemoglobinopathies and beta-thalassemia.
arimoclomol |  | Treatment of amyotrophic lateral sclerosis
Aripiprazole | Abilify | Treatment of Tourette's syndrome
arsenic | Trisenox | Treatment of acute myelocytic leukemia subtypes M0, M1, [NAME], [NAME], M5, M6 and M7
Arsenic trioxide | Trisenox | Treatment of malignant glioma
arsenic trioxide | Trisenox | Treatment of chronic myeloid leukemia
Arsenic trioxide | Trisenox | Treatment of multiple myeloma.
arsenic trioxide | Trisenox | Treatment of liver cancer
Arsenic trioxide | Trisenox | Treatment of chronic lymphocytic leukemia
arsenic trioxide | Trisenox | Treatment of myelodysplastic syndrome.
artemether/lumefantrine | Coartem | For the treatment of infections due to Plasmodium falciparum or mixed infections including P. falciparum.
Artesunate |  | Treatment of malaria.
Artesunate |  | Immediate treatment of malaria
arylsulfatase A (rhARSA) |  | Treatment of metachromatic leukodystrophy.
As-101 |  | Treatment of acquired immunodeficiency syndrome.
Ascorbic acid | Ascor L 500 | Treatment of scurvy
Atomoxetine hydrochloride | STRATTERA | Treatment of Tourette's Syndrome
Atovaquone | Mepron | Primary prophylaxis of HIV-infected persons at high risk for developing Toxoplasma gondii encephalitis.
Atovaquone | Mepron | Treatment and suppression of Toxoplasma gondii encephalitis.
Attenuated autologous cancer cells and granulocyte macrophage colony stimulating factor in combination with activated autologous blood derived T-cells |  | Treatment of primary central nervous system malignancies
autologous antigen presenting cells pulsed with autologous tumor Ig idiotype | Mylovenge | Treatment of multiple myeloma
Autologous cultured endothelial cells on a donor human corneal disk |  | Treatment of Fuch's dystrophy, [NAME] bullous [NAME], and bullous [NAME]
Autologous dendritic cells pulsed with autologous antigens from primay malignant brain tumor cells | DCVax-Brain | Treatment of primary brain malignant cancer
Autologous DNP-conjugated tumor vaccine | M-Vax | For adjuvant therapy in melanoma patients with surgically resectable lymph node metastasis (Stage III and limited Stage IV disease).
Autologous incubated macrophage |  | Therapy to improve the motor and sensory neurological outcome in acute cases of spinal cord injury
autologous lymphocytes depleted ex vivo of immunoreactive T cells using 4,5 | Theralux photodynamic therapy | Treatment of chronic graft versus host disease
autologous olfactory neural progenitors | RhinoCytes | Treatment of amyotrophic lateral sclerosis
Autologous olfactory neural progenitors | RhinoCytes | Treatment of spinal cord injury patients with ASIA Impairment grades A, B, or C
Autologous or allogeneic [NAME] stem cells expanded ex vivo on human amniotic membrane |  | Treatment of ocular surface diseases that are characterized by total limbal stem cell deficiency
autologous tumor-derived gp96 heat shock protein-peptide complex | Oncophage | Treatment of renal cell carcinoma
autologous tumor-derived gp96 heat shock protein-peptide complex | Oncophage | Treatment of metastatic melanoma
[NAME] therapy |  | Treatment of renal cell carcinoma.
aviptadil |  | Treatment of pulmonary arterial hypertension
axitinib |  | Treatment of pancreatic cancer
Azathioprine | Imuran | Treatment of oral manifestations of graft-versus-host disease.
aztreonam |  | Inhalation therapy for control of gram-negative bacteria in the respiratory tract of patients with cystic fibrosis
[NAME] vaccine |  | Treatment of stage IIb through IV metastatic melanoma
Bacitracin | Altracin | Treatment of antibiotic-associated pseudomembranous enterocolitis caused by toxins A and B elaborated by Clostridium difficile.
Baclofen |  | Treatment of intractable spasticity due to multiple sclerosis or spinal cord injury.
Baclofen | [NAME] | Treatment of spasticity associated with cerebral palsy.
baclofen |  | Treatment of dystonia
Bardoxolone |  | Treatment of pancreatic cancer
beclomethasone |  | Treatment of pediatriac patients with ulcerative colitis
[NAME]-dipropionate | Bec | Prevention of gastrointestinal graft-versus-host disease
[NAME] |  | Treatment of pediatric patients with Crohn disease.
Beclomethasone dipropionate |  | For oral administration in the treatment of intestinal graft-versus-host disease.
belatacept |  | Prophylaxis of organ rejection in renal allograft recipients
Benzophenone-3, octylmethoxycinnamate, avobenzone, titanium dioxide, zinc oxide | Total Block VL SPF 75 | For the prevention of visible light induced skin photosensitivity as a result of porfimer sodium photodynamic therapy
Benzydamine hydrochloride | Tantum | Prophylactic treatment of oral mucositis resulting from radiation therapy for head and neck cancer.
[NAME], benzylpenicilloic, benzylpenilloic acid | Pre-Pen/MDM | Assessing the risk of administrating penicillin when it is the preferred drug of choice in adult patients who have previously received penicillin and have a history of clinical sensitivity.
Beractant | [NAME] | Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.
Beraprost |  | Treatment of pulmonary arterial hypertension associated with any New York Heart Association classification (Class I, II, III, or IV).
Beta alethine | Betathine | Treatment of metastatic melanoma.
Beta alethine | Betathine | Treatment of multiple myeloma.
Betahistine dihydrochloride |  | Treatment of obesity associated with [NAME] syndrome
Bethanidine sulfate |  | Prevention of recurrence of primary ventricular fibrillation.
Bethanidine sulfate |  | Treatment of primary ventricular fibrillation.
Betulinic acid |  | Topical treatment of metastatic melanoma
Bevacizamub | Avastin | Treatment of malignant glioma
[NAME] | Avastin | Therapeutic treatment of patients with ovarian cancer
[NAME] | Avastin | Treatment of pancreatic cancer
[NAME] | Avastin | Treatment of renal cell carcinoma
bifidobacterium infantis 35624 |  | Treatment of pediatric ulcerative colitis
[NAME] |  | Treatment of pediatric Crohn's disease
Bindarit |  | Treatment of lupus nephritis.
Bioartificial liver system utilizing xenogenic hepatocytes in a hollow fiber bioreactor cartridge (BAL) |  | Treatment of patients with acute liver failure presenting with encephalopathy deteriorating beyond Parson's grade 2
Bio-engineered oral mucosal tissue |  | For use as a graft for restoring a cornea-like epithelial phenotype to  substitute for the normal corneal epithelium that is lost in patients due to total limbal stem cell deficiency
Bis(4-fluorophenyl)phenylacetamide |  | Treatment of sickle cell disease.
Bispecific molecule with two linked murine single-chain Fv regions against CD3 & CD19 |  | Treatment of prolymphocytic leukemia
Bispecific molecule with two linked murine single-chain Fv regions against CD3 & CD19 |  | Treatment for hairy cell leukemia.
Bispecific molecule with two linked murine single-chain Fv regions against CD3 & CD19 |  | Treatment of chronic lymphocytic leukemia
Bispecific molecule with two linked murine single-chain Fv regions against CD3 & CD19 |  | Treatment of acute lymphocytic leukemia
Bispecific molecule with two linked murine single-chain Fv regions directed against CD3 & CD19 |  | Treatment of indolent B-cell lymphoma, excluding CLL and NHL with CNS involvement
bivalirudin | Angiomax | For use as an anticoagulant in patients with or at risk of heparin-induced thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome
Bleomycin | Blenoxane | Treatment of pancreatic cancer.
BMY-45622 |  | Treatment of ovarian cancer.
bosentan | Tracleer | Treatment of idiopathic pulmonary fibrosis
bosutinib |  | Treatment of chronic myelogenous leukemia.
Botulinum toxin type A | Dysport | Treatment of dynamic muscle contractures in pediatric cerebral palsy patients.
Botulinum toxin type A | Dysport | Treatment of spasmodic torticollis (cervical dystonia).
Botulinum toxin type A | Dysport | Treatment of essential blepharospasm.
Botulinum toxin type A | Botox | Treatment of dynamic muscle contracture in pediatric cerebral palsy patients.
Botulinum toxin type A |  | Treatment of synkinetic closure of the eyelid associated with VII cranial nerve aberrant regeneration.
Botulinum toxin type F |  | Treatment of spasmodic torticollis (cervical dystonia).
Botulinum toxin type F |  | Treatment of essential blepharospasm.
Bovine colostrum |  | Treatment of AIDS-related diarrhea.
Bovine immunoglobulin concentrate, Cryptosporidium parvum | [NAME] | Treatment and symptomatic relief of Cryptosporidium parvum infection of the gastrointestinal tract in immunocompromised patients.
Bovine whey protein concentrate | Immuno-C | Treatment of cryptosporidiosis caused by the presence of Cryptosporidium parvum in the gastrointestinal tract of patients who are immunodeficient/immunocompromised or immunocompetent.
Branched chain amino acids |  | Treatment of amyotrophic lateral sclerosis.
Brimonidine | Alphagan | Treatment of anterior ischemic optic neuropathy.
Brivaracetam |  | Treatment of symtomatic myoclonus
Brivudin |  | Adjunct treatment of pancreatic cancer
Bromhexine | [NAME] | Treatment of mild to moderate keratoconjunctivitis sicca in patients with [NAME]'s syndrome.
Broxuridine | Broxine/Neomark | Radiation sensitizer in the treatment of primary brain tumors.
bryostatin-1 |  | For use in combination with paclitaxel in the treatment of esophageal cancer
Buffered Ursodeoxycholic Acid | Ursocarb | Treatment of pruritus in patients with Alagille Syndrome
bupivacaine | Transdur | Relief of persistent pain asociated with postherpetic neuralgia
Busulfan | Spartaject | For use as preparative therapy for malignancies treated with bone marrow transplantation.
Busulfan | Spartajet-Busulfan | Intrathecal therapy for neoplastic meningitis
busulfan | Partaject | Preparative therapy for pediatric patients undergoing bone marrow transplantation
Busulfan | Spartaject | Treatment of primary brain malignancies.
Buthionine sulfoxamine |  | For use in children as a modulator of chemotherapy for the treatment of pediatric patients with neuroblastoma
Buthionine sulfoxamine |  | Use as a modulator of chemotherapy for the treatment of pediatric patients with primary malignant brain tumors
Butyrylcholinesterase |  | Treatment of post-surgical apnea.
Butyrylcholinesterase |  | For the reduction and clearance of toxic blood levels of cocaine encountered during a drug overdose.
BW 12C |  | Treatment of sickle cell disease.
C1 esterase inhibitor (human) |  | Treatment and prevention of angioedema caused by C1-esterase inhibitor deficiency.
C1-esterase-inhibitor, human, pasteurized | [NAME] | Prevention and/or treatment of acute attacks of hereditary angioedema.
C1-inhibitor | C1-inhibitor (human) vapor heated, [NAME] | Prevention of acute attacks of angioedema, including short-term prophylaxis for patients requiring dental or other surgical procedures.
C1-inhibitor | C1-inhibitor (human) vapor heated, [NAME] | Treatment of acute attacks of angioedema.
cAC10-vcMMAE (4) |  | Treatment of Hodgkin's lymphoma.
Calcitonin salmon nasal spray | [NAME] | Treatment of symptomatic Paget's disease (osteitis deformans).
Calcium acetate |  | Treatment of hyperphosphatemia in end stage renal disease.
Calcium carbonate | R & D calcium carbonate/600 | Treatment of hyperphosphatemia in patients with end stage renal disease.
Calcium gluconate | Calgonate | For use as a wash for hydrofluoric acid spills on human skin.
Calcium gluconate gel | H-F Gel | For use in the emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.
Calcium gluconate gel 2.5% |  | Emergency topical treatment of hydrogen fluoride (hydrofluoric acid) burns.
Calfactant | Infasurf | Acute respiratory distress syndrome (ARDS)
canakinumab |  | Treatment of systemic onset juvenile idiopathic arthritis
Capsaicin |  | Treatment of postherpetic neuralgia.
Capsaicin |  | Treatment of intermetatarsal neuroma ([NAME]'s Neuroma) that does not respond to conservative treatment and requires either neurectomy or neurolysis
capsaicin |  | Treatment of erythromelalgia
Capsaicin |  | Treatment of painful HIV-associated neuropathy
Carbamylglutamic acid |  | Treatment of N-acetylglutamate synthetase deficiency.
carbon monoxide | Covox | For use in the reduction of the incidence and severity of delayed graft function in patients undergoing solid organ transplanation.
Carbovir |  | Treatment of persons with AIDS and in patients with symptomatic HIV infection and a CD4 count less than 200/mm3.
cardiotrophin-1 |  | To protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation.
carfilzomib |  | Treatment of multiple myeloma
Carmustine |  | Treatment of intracranial malignancies.
Cascara sagrada fluid extract |  | Treatment of oral drug overdosage to speed lower bowel evacuation.
[NAME] | [NAME] | Treatment of ovarian cancer
CD4 human truncated 369 AA polypeptide | Soluble T4 | Treatment of acquired immunodeficiency syndrome.
CD5-T lymphocyte immunotoxin | Xomazyme-H65 | Treatment of graft versus host disease and/or rejection in patients who have received bone marrow transplants.
CDP571 |  | Treatment of Crohn's disease.
CDX-110 |  | Treatment of EGFRvIII-expressing glioblastoma multiforme
Ceftriaxone sodium | Rocephin | Treatment of amyotrophic lateral sclerosis
Cells produced using the AastromReplicelle System and SC-I Therapy Kit |  | For use in patients receiving high dose chemotherapy who are unable to generate an acceptable dose of peripheral blood stem cells and who have a sufficient bone marrow aspirate without morphological evidence of tumor
cenersen | Aezea | Treatment of stage IIB through IV melanoma
cenersen |  | Treatment of acute myeloid leukemia
cenersen | Aezea | Treatment of chronic lymphocytic leukemia
Centruroides immune F(ab)2 | [NAME] | Treatment of scorpion envenomations requiring medical attention.
cethromycin |  | Prophylactic treatment of patients exposed to inhalation anthrax.
Cetiedil citrate injection |  | Treatment of sickle cell disease crisis.
cetuximab | Erbitux | Treatment of pancreatic cancer
Chenodeoxycholic acid | Chenofalk | Treatment of cerebrotendinous xanthomatosis
chenodeoxycholic acid |  | Treatment of cerebrotendinous xanthomatosis
Chimeric (human-murine) G250 IgG monoclonal antibody |  | Treatment of renal cell carcinoma.
chimeric (murine-human) IgG1 mAb against IL-6 |  | Treatment of multiple myeloma
Chimeric (murine-human) IgG1k monoclonal antibody against interleukin-6 |  | Treatment of [NAME]'s disease
Chimeric monoclonal antibodies |  | For treatment of shiga-toxin producing bacterial infection.
Chimeric monoclonal antibody to mesothelin |  | Treatment of pancreatic cancer
[NAME] (human-murine) IgG monoclonal anti-CD4 |  | Treatment of multiple sclerosis.
[NAME]/human IgG1 monoclonal antibody to human interleukin-3 receptor alpha chain |  | Treatment of acute myeloid leukemia
Chimeric, humanized monoclonal antibody to staphylococcus |  | Prophylaxis of Staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants.
Chlorhexidine gluconate mouthrinse | Peridex | For use in the amelioration of oral mucositis associated with cytoreductive therapy used in conditioning patients for bone marrow transplantation therapy.
chlorotoxin |  | Treatment of stage IIb, IIc, III & IV melanoma
Chlorotoxin |  | Treatment of malignant glioma
cholest-4-en-3-one, oxime |  | Treatment of spinal muscular atrophy.
cholic acid (3 alpha, 7 alpha, 12 alpha trihydroxy 5-beta cholanolic acid) | Falkochol | Treatment of inborn errors of cholesterol and bile acid synthesis and  metabolism
Choline chloride | IntraChol | Prevention and/or treatment of choline deficiency in patients on long-term parenteral nutrition
Choline chloride | Intrachol | Treatment of choline deficiency, specifically the choline deficiency, hepatic steatosis, and cholestasis, associated with long-term parenteral nutrition.
Chondrocyte-alginate gel suspension |  | For use in correcting vesicoureteral reflux in the pediatric population.
Chondroitinase |  | Treatment of patients undergoing vitrectomy.
cicletanine hydrochloride |  | Treatment for pulmonary arterial hypertension.
cilengitide |  | Treatment of malignant glioma
[NAME] neurotrophic factor |  | Treatment of amyotrophic lateral sclerosis.
[NAME] neurotrophic factor, recombinant human |  | Treatment of motor neuron disease (including amyotrophic lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and primary lateral sclerosis).
[NAME] neurotrophic factor, recombinant human |  | Treatment of spinal muscular atrophies.
[NAME] in liposomal formulation | SLIT Cisplatin for inhalation | Treatment of osteogenic sarcoma metastatic to the lung
Cisplatin/epinephrine | IntraDose | Treatment of metastatic malignant melanoma.
Cisplatin/epinephrine | IntraDose | Treatment of squamous cell carcinoma of the head and neck.
Civamide | Zucapsaicin | Treatment of postherpetic neuralgia of the trigeminal nerve
Cladribine | Leustatin | Treatment of acute myeloid leukemia.
Cladribine | [NAME] | Treatment of chronic lymphocytic leukemia.
Cladribine | Mylinax | Treatment of the chronic progressive form of multiple sclerosis.
Cladribine | [NAME] | Treatment of [NAME] lymphoma.
Clazosentan | Erajet | Treatment of cerebral vasospasm following subarachnoid hemorrhage
Clindamycin | [NAME] | Prevention of Pneumocystis carinii pneumonia in AIDS patients.
Clindamycin | [NAME] | Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.
Clindamycin hydrochloride |  | Treatment of sarcoidosis
clobazam |  | Treatment of Lennox-Gastaut Syndrome.
clofarabine | Clofarex | Treatment of acute myelogenous leukemia
Clonazepam | Klonopin | Treatment of hyperekplexia (startle disease).
Clonazepam [NAME] |  | Treatment of recurrent acute repetitive seizures
Clostridial collagenase |  | Treatment of advanced (involutional or residual stage) [NAME]'s disease.
Clotrimazole |  | Topical treatment of children and adults with pouchitis
Clotrimazole |  | Treatment of Huntington's disease
Clotrimazole |  | Treatment of sickle cell disease.
c-myb antisense oligodeoxynucleotide |  | Treatment of chronic myelogenous leukemia
Coagulation factor VIIa (recombinant) | NovoSeven | Prevention of bleeding episodes in Glanzmann's thrombasthenia
Coagulation factor VIIa (Recombinant) | NovoSeven | Treatment of bleeding episodes in Glanzmann's thrombasthenia
Coagulation Factor VIIa (Recombinant) | NovoSeven | Treatment of bleeding in patients experiencing intracranial hemorrhage.
cobiprostone |  | Treatment of cystic fibrosis
coccidioidin SD Skin Test Antigen |  | For the diagnosis of Coccidioidomycosis.
Coenzyme Q10 |  | Treatment of Huntington's disease
Colchicine |  | Treatment of familial Mediterranean fever
Colchicine |  | Treatment of Behcet's Syndrome
Colchicine |  | For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis.
Collagenase (lyophilized) for injection | Plaquase | Treatment of [NAME]'s disease.
[NAME] phosphate |  | Treatment of ovarian cancer
[NAME] |  | Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and stage IV papillary or follicular thyroid cancer
conjugate of human transferrin and a mutant diphtheria toxin (CRM 107) | TransMID | Treatment of malignant tumors of the central nervous system
conjugated bile acids | COBARTin | Treatment of steatorrhea in patients with short bowel syndrome
Contulakin-G |  | Intrathecal treatment of neuropathic pain associated with spinal cord injury
Cordycepin |  | Treatment of TdT-positive acute lymphocytic leukemia
Corticotropin-releasing factor, human | Xerecept | Treatment of peritumoral brain edema.
Coumarin | Onkolox | Treatment of renal cell carcinoma.
[NAME] | Cavatak | Treatment of stage II (T4), stage III, and stage IV melanoma
[NAME] | Creapure | Treatment of Huntington's disease
creatine | Creapure | Treatment of amyotrophic lateral sclerosis
Cry5B |  | Treatment of soil transmitted helminth infection strongyloidiasis
Cryptosporidium hyperimmune bovine colostrum IgG concentrate |  | Treatment of diarrhea in AIDS patients caused by infection with Cryptosporidium parvum.
cultured, partially T-Cell depleted, allogenic thymic tissue for transplantation |  | As a therapy for primary immune deficiency resulting from athymia associated with complete DiGeorge Syndrome
CY-1503 | Cylexin | Treatment of neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions.
CY-1503 | Cylexin | Treatment of post-ischemic pulmonary reperfusion edema following surgical treatment for chronic thromboembolic pulmonary hypertension.
CY-1899 |  | Treatment of chronic active hepatitis B infection in HLA-A2 positive patients.
Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobytyrl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl} |  | Treatment and chronic control of non-infectious posterior, intermediate and pan-uveitis
Cyclosporin A | Mitogard | Treatment of amyotrophic lateral sclerosis and its variants
cyclosporine |  | Prophylaxis of graft-versus-host disease
cyclosporine |  | Treatment of graft-versus-host disease
Cyclosporine |  | Prophylaxis of organ rejection in patients receiving allogeneic lung transplant
Cyclosporine | Pluminiq | Treatment of acute rejection in patients requiring allogenic lung transplants
Cyclosporine 2% ophthalmic ointment |  | Treatment of patients at high risk of graft rejection following penetrating keratoplasty.
Cyclosporine 2% ophthalmic ointment |  | For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including [NAME]'s ulcer.
Cyclosporine A |  | Treatment of vernal keratoconjunctivitis
cyclosporine A |  | Prevention of corneal graft rejection
cyclosporine A | NOVA22007 | Treatment of herpes simplex virus stromal keratitis
Cyclosporine A implant |  | For the prevention of acute rejection in cornea transplant patients
Cyclosporine in combination with omega-3 polyunsaturated fatty acids |  | Prevention of solid organ graft rejection.
Cyclosporine ophthalmic | Optimmune | Treatment of severe keratoconjunctivitis sicca associated with [NAME]'s syndrome.
Cyproterone acetate | Androcur | Treatment of severe hirsutism.
[NAME] |  | For use in conjunction with melphalen for the treatment of malignant melanoma, AJCC stages IIB, IIC, III and IV
cysteamine |  | Treatment of neuronal ceroid lipofuscinoses (Batten disease)
cysteamine |  | Treatment of Huntington's disease
Cysteamine |  | Treatment of nephropathic cystinosis.
[NAME] hydrochloride |  | Treatment of corneal cystine crystal accumulation in cystinosis patients.
Cystic fibrosis gene therapy |  | Treatment of cystic fibrosis.
Cystic fibrosis Tr gene therapy (recombinant adenovirus) | AdGVCFTR.10 | Treatment of cystic fibrosis.
Cystic fibrosis transmembrane conductance regulator |  | For cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis patients.
Cystic fibrosis transmembrane conductance regulator gene |  | Treatment of cystic fibrosis.
cytarabine liposome | DepoCyt | Treatment of gliomas
Cytarabine:daunorubicin liposome injection |  | Treatment of acute myeloid leukemia
Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride |  | For use in prevention of clinically significant CMV viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid organ transplant populations
Cytomegalovirus DNA vaccine with plasmids expressing pp65 and [NAME] genes |  | Prevention of clinically significant cytomegalovirus (CMV) viremia, CMV disease and asociated complications in at-risk hematopoietic cell transplant and solid transplant populations
Cytomegalovirus immune globulin intravenous (human) |  | For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients.
[NAME] sodium | Dantrium | Treatment of the neuroleptic malignant syndrome.
Dapsone |  | Prophylaxis of toxoplasmosis in severely immunocompromised patients with CD4 counts below 100.
Dapsone USP | Dapsone | For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.
Dapsone USP | Dapsone | Prophylaxis for Pneumocystis carinii pneumonia.
Daunorubicin liposomal |  | Treatment of acute myeloid leukemia
DEAE-rebeccamycin |  | Treatment of bile duct tumors
debrase | Debridase | Debridement of acute, deep dermal burns in hospitalized patients
Decitabine | Dacogen | Treatment of acute myeloid leukemia
decitabine |  | Treatment of sickle cell anemia
Decitabine |  | Treatment of chronic myelogenous leukemia.
deferiprone |  | Treatment of Friedreich's ataxia.
deferiprone | Ferriprox | Treatment of iron overload in patients with hematologic disorders requiring chronic transfusion therapy
deferoxamine-starch conjugate |  | Treatment of acute iron poisoning.
defibrotide |  | For the prevention of hepatic veno-occlusive disease.
Defibrotide |  | For the treatment of hepatic veno-occlusive disease
Defibrotide |  | Treatment of thrombotic thrombocytopenic purpura.
Dehydroepiandrosterone |  | Treatment of systemic lupus erythematosus (SLE) and the reduction in the use of steroids in steroid-dependent SLE patients.
Dehydroepiandrosterone (DHEA) | [NAME] | Replacement therapy in individuals with adrenal insufficiency
Dehydroepiandrosterone sulfate sodium |  | Treatment of serious burns requiring hospitalization.
Dehydroepiandrosterone sulfate sodium |  | To accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting.
Deslorelin | Somagard
[NAME] 3 synthetic peptide (PI-0824) |  | Treatment of pemphigus vulgaris
Dexamethasone | Posurdex | For use in posterior segment drug delivery system in the treatment of idiopathic intermediate uveitis.
dexamethasone phosphate |  | Treatment of corneal graft rejection.
dexanabinol |  | For the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injury
dextran 1 |  | Treatment of cystic fibrosis
[NAME] 70 | Dehydrex | Treatment of recurrent corneal erosion unresponsive to conventional therapy.
Dextran and deferoxamine | Bio-Rescue | Treatment of acute iron poisoning.
[NAME] sulfate (inhaled, aerosolized) | Uendex | For use as an adjunct to the treatment of cystic fibrosis.
Dextran sulfate sodium |  | Treatment of aquired immunodeficiency syndrome.
DHA-paclitaxel | Taxoprexin | Treatment of pancreatic cancer
DHA-paclitaxel | Taxoprexin | Treatment of adenocarcinoma of the stomach or lower esophagus
DHA-paclitaxel | Taxoprexin | Treatment of metastatic malignant melanoma
Dianeal peritoneal dialysis solution with 1.1% amino acids | Nutrineal (Peritoneal Dialysis Solution with 1.1% Amino Acid | For use as a nutritional supplement for the treatment of malnourishment in patients undergoing continuous ambulatory peritoneal dialysis.
Diaziquone |  | Treatment of primary brain malignancies (grade III and IV astrocytomas).
Dideoxyinosine |  | Treatment of acquired immunodeficiency syndrome.
Diethyldithiocarbamate | Imuthiol | Treatment of AIDS.
diethylenetriaminepentaacetate ([NAME]) |  | For treatment of patients with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination.
Diethylnorspermine (DENSPM) |  | Treatment for hepatocellular carcinoma
diferuloylmethane |  | Treatment of cystic fibrosis
difluprednate | Durezol | Treatment of endogenous and traumatic anterior uveitis and panuveitis.
Digitoxin |  | Treatment of cystic fibrosis
digitoxin |  | Treatment of soft tissue sarcomas
digitoxin |  | Treatment of ovarian cancer
Digoxin immune fab(ovine) | Digidote | Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia.
dihydroartemisinin and piperaquine | Eurartesim | Treatment of uncomplicated malaria caused by "Plasmodium falciparum," Plasmodium vivax," Plasmodium malariae," or "Plasmodium ovale."
Dihydrotestosterone | Androgel -DHT | Treatment of weight loss in AIDS patients with HIV-associated wasting.
dimethyl sulfoxide |  | For use in combination with antimicrobial drugs for the treatment of drug resistant tuberculosis
Dimethyl sulfoxide |  | Treatment of increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available.
Dimethyl sulfoxide |  | Treatment of cutaneous manifestations of scleroderma.
Dimethylsulfoxide |  | Treatment of palmar-plantar erythrodysethesia syndrome.
Dimethylsulfoxide |  | Topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs.
Dipalmitoylphosphatidylcholine /phosphatidylglycerol | ALEC | Prevention and treatment of neonatal respiratory distress syndrome.
diphenylcyclopenone |  | Treatment of chronic severe forms of alopecia areata ([NAME] [AT]/Alopecia Universalis [AU])
Disaccharide tripeptide glycerol dipalmitoyl | Immther | Treatment of pulmonary and hepatic metastases in patients with colorectal adenocarcinoma.
Disodium clodronate |  | Treatment of hypercalcemia of malignancy.
Disodium clodronate tetrahydrate | Bonefos | Treatment of increased bone resorption due to malignancy.
Disodium silibinin dihemisuccinate | Legalon | Treatment of hepatic intoxication by [NAME] phalloides (mushroom poisoning).
D-mannitol and L-proline | Prodarsan(r) | Treatment of Cockayne syndrome
DMP 777 |  | Therapeutic management of patients with lung disease attributable to cystic fibrosis.
DNA plasmid vector expressing human IL-12 gene |  | Treatment of ovarian cancer.
DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2 | Leuvectin | Treatment of renal cell carcinoma.
DNP-Modified autologous tumor vaccine | O-Vax | Adjuvant therapy for the treatment of ovarian cancer
docosahexanoic acid-paclitaxel | Taxoprexin | Treatment of hormone-refractory prostate cancer.
[NAME] |  | Treatment of bronchopulmonary infection in patients with cystic fibrosis who are colonized with Pseudomonas aeruginosa or Burkholderia cepacia.
Dovitinib |  | Treatment of multiple myeloma
[NAME] HCl with pluronic L-61 and pluronic F-127 |  | Treatment of esophageal carcinoma
doxorubicin PIHCA nanoparticles | [NAME] | Treatment of hepatocellular carcinoma
doxorubicin with pluronics F-127 and L-61 |  | Treatment of gastric cancer
D-peptide of the sequence AKRHHGYKRKFH - NH2 | PulmaDex | Treatment of cystic fibrosis
D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-Nh2 (disulfide bridge: 2-6) acetate |  | Treatment of melanoma, stages IIb through IV
droxidopa |  | Treatment of neurogenic symptomatic orthostatic hypotension in patients with primary autonomic failure, dopamine-beta-hydroxylase deficiency, and nondiabetic autonomic neuropathy.
Duramycin |  | Treatment of cystic fibrosis.
Dynamine |  | Treatment of hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease).
Dynamine |  | Treatment of [NAME] myasthenic syndrome.
ecallantide | Kalbitor | Treatment of angioedema
eculizumab | Soliris(r) | Treatment of atypical hemolytic uremic syndrome
eculizumab |  | Treatment of idiopathic membranous glomerular nephropathy
Eculizumab |  | Treatment of dermatomyositis
Edotreotide | OctreoTher | Treatment of somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors
efaproxiral |  | Adjunct to whole brain radiation therapy for the treatment of brain metastases in patients with breast cancer
Eflornithine |  | Treatment of anaplastic glioma
[NAME] | Ornidyl | Treatment of Pneumocystis carinii pneumonia in AIDS patients.
Elcatonin |  | Intrathecal treatment of intractable pain.
Enadoline hydrochloride |  | Treatment of severe head injury.
Encapsulated porcine islet preparation | BetaRx | Treatment of type I diabetic patients who are already on immunosuppression.
eniluracil |  | Treatment of hepatocellular carcinoma
Enisoprost |  | For use in organ transplant patients to diminish the nephrotoxicity induced by cyclosporine.
Enisoprost |  | For use with cyclosporine in organ transplant recipients to reduce acute transplant rejection.
Enteric-coated cysteamine |  | Treatment of cystinosis
enzastaurin |  | Treatment of diffuse large B-cell lymphoma
Enzastaurin |  | Treatment of glioblastoma multiforme
Epidermal growth factor (human) |  | For acceleration of corneal epithelial regeneration and the healing of stromal tissue in the condition of non-healing corneal defects.
Epidermal growth factor (human) |  | For promotion of cutaneous wound healing in extreme burn treatment protocols.
Epoetin alfa |  | Treatment of myelodysplastic syndrome.
Epoetin alpha | Procrit | Treatment of anemia associated with end stage renal disease.
Epoetin alpha | Procrit | Treatment of anemia of prematurity in preterm infants.
Epoetin alpha | Procrit | Treatment of HIV associated anemia related to HIV infection or HIV treatment.
Epoetin beta | Marogen | Treatment of anemia associated with end stage renal disease.
Epoprostenol | Flolan | Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage.
Epoprostenol | Cycloprostin | Replacement of heparin in patients requiring hemodialysis and who are at increased risk of hemorrhage.
[NAME] |  | Treatment of acute lymphoblastic leukemia
[NAME] | LymphoCIDE | Treatment of [NAME] lymphoma.
Eprodisate | Fibrillex | Treatment of secondary amyloidosis
[NAME] specific cytotoxic T lymphocytes |  | Prevention and treatment of EBV-post transplant lymphoproliferative disease after hematopoietic stem cell transplant or solid organ transplant.
Erlotinib Hydrochloride | Tarceva | Treatment of malignant gliomas
[NAME] | Erwinase | Treatment of acute lymphocytic leukemia.
[NAME] |  | For use as an alternative to E. coli asparaginase in those situations where repeat courses of asparaginase therapy for acute lymphoblastic leukemia are required or where allergic reactions force the discontinuance of the E. coli preparation.
Erythropoietin (human, recombinant) |  | Treatment of anemia associated with end stage renal disease.
Erythropoietin (recombinant human) |  | Treatment of anemia associated with end stage renal disease.
[NAME] | EstroGel (r) | Estrogen replacement therapy in females with Turner syndrome
Etanercept | Enbrel | Treatment of Wegener's granulomatosis.
Ethanol gel |  | Treatment of congenital lymphatic malformations
Ethanol gel |  | Treatment of congenital venous malformations
[NAME], USP |  | Treatment of Turner's syndrome.
Ethiofos |  | Use as a chemoprotective agent for cisplatin and cyclophosphamide in the treatment of ovarian cancer.
Ethyl eicosapentaenoate |  | Treatment of Huntington's disease.
Etidronate disodium | Didronel IV infusion | Prevention of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.
Etidronate disodium | Didronel IV Infusion | Treatment of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition.
Etiocholanedione |  | Treatment of Prader-Willi syndrome.
Etiocholanedione |  | Treatment of aplastic anemia.
everolimus |  | Treatment of gastroenteropancreatic neuroendocrine tumors
Ex vivo cultured adult human mesenchymal stem cells | Prochymal | Treatment of acute graft versus host disease
Exisulind |  | For the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli.
Factor XIII [A2] homodimer, recombinant DNA origin |  | Treatment of congenital FXIII deficiency
Factor XIII [A2} homodimer, recombinant DNA origin |  | For the prophylaxis of bleeding associated with congential FXIII deficiency
factor [NAME] concentrate (human), pasteurized | [NAME] | Treatment of congenital factor [NAME] deficiency.
Factor XIII, recombinant |  | Treatment of congenital factor [NAME] deficiency.
Fampridine | Neurelan | Relief of symptoms of multiple sclerosis.
Fampridine | Neurelan | Treatment of chronic, incomplete spinal cord injury.
Fenobam hydrochloride |  | Treatment of fragile X syndrome
fenretinide |  | Treatment of Ewing's sarcoma family of tumors.
Fenretinide |  | Treatment of neuroblastoma
ferric hexacyanoferrate (II) "Prussian Blue" |  | Treatment of patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium
FIAU |  | Adjunctive treatment of chronic active hepatitis B.
Fibrinogen (human) |  | For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen.
Fibronectin (human plasma derived) |  | Treatment of non-healing corneal ulcers or epithelial defects which have been unresponsive to conventional therapy and the underlying cause has been eliminated.
Fibronectin (plasma derived) |  | Treatment of non-healing corneal ulcers or epithelial defects which are unresponsive to conventional therapy and for which any infectious cause of the defect has been eliminated.
Filgrastim | Neupogen | Treatment of myelodysplastic syndrome.
Filgrastim | Neupogen | Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir.
Floxuridine, FUDR |  | Intraperitoneal treatment of gastric cancer.
Fludarabine phosphate | Fludara | Treatment and management of patients with non-Hodgkins lymphoma.
Flumecinol | Zixoryn | Treatment of hyperbilirubinemia in newborn infants unresponsive to phototherapy.
Flunarizine | Sibelium | Treatment of alternating hemiplegia.
Fluorouracil | Adrucil | For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum.
Fluorouracil |  | For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma.
Fluorouracil |  | For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.
Fluorouracil |  | Treatment of glioblastoma multiforme.
Fluoxetine | [NAME] | Treatment of autism.
Fluoxetine | [NAME] | Treatment of body dysmorphic disorder in children and adolescents
fosfomycin/tobramycin |  | Treatment of pulmonary infections associated with cystic fibrosis.
Fructose-1,6-diphosphate | Cordox | Treatment of painful vaso-occlusive episodes associated with sickle cell disease.
Full Phosphorothioate Antisense Oligonucleotide against EWS-Fli-1 nanoparticles |  | Treatment of Ewing's sarcoma
Fully Human Anti-MCP-1/CCL2 Monoclonal Antibody |  | Treatment of idiopathic pulmonary fibrosis.
Fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1 |  | Treatment of X-linked hypohidrotic ectodermal dysplasia
G17DT Immunogen |  | Treatment of gastric cancer
G17DT Immunogen |  | Treatment of adenocarcinoma of the pancreas
Gabapentin | Neurontin | Treatment of amyotrophic lateral sclerosis.
Gamma hydroxybutyrate |  | Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations and automatic behavior.
Gamma-hydroxybutyric acid |  | Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations, and automatic behavior.
Gammalinolenic acid |  | Treatment of juvenile rheumatoid arthritis.
Ganaxolone |  | Treatment of infantile spasms.
Ganciclovir | Virgan | Treatment of acute herpetic [NAME] (dendritic and geographic ulcers)
Gancyclovir |  | Treatment of severe human cytomegalovirus infections in specific immunosuppressed patient populations.
Gangliosides as sodium salts | Cronassial | Treatment of retinitis pigmentosa.
[NAME] |  | Acute graft-versus-host disease (aGVHD)
gene encoding chimeric CD40 ligand |  | Treatment of chronic lymphocytic leukemia
Gene plasmid hVEGF165 driven by human cytomegalovirus, and [2,3-bis(oleoyl)propyl]trimethyl ammonium and [NAME] | Trinam | Prevention of complications due to neointimal hyperplasia disease in certain vascular anastomoses.
genetically engineered herpes simplex virus (G207) |  | Tretament of malignant glioma
Geneticin |  | Treatment of amoebiasis.
Gentamicin impregnated PMMA beads on surgical wire | Septopal | Treatment of chronic osteomyelitis of post-traumatic, postoperative, or hematogenous origin.
Gentamicin liposome injection | Maitec | Treatment of disseminated Mycobacterium avium-intracellulare infection.
[NAME] | Copaxone | Treatment of amyothrophic lateral sclerosis (ALS).
Glatiramer acetate for injection | Copaxone | Treatment of primary-progressive multiple sclerosis
glucarpidase | Voraxaze | Treatment of patients at risk of methotrexate toxicity
glufosfamide |  | For treatment of pancreatic cancer.
Glycafilin |  | Prevention of delayed graft function after solid organ transplantation
Glyceol |  | To decrease intracranial hypertension and/or alleviate cerebral edema in patients who may benefit from osmotherapy.
[NAME] (4-phenylbutyrate) |  | Treatment of spinal muscular atrophy
[NAME] (4-phenylbutyrate) |  | Maintenance treatment of patients with deficiencies in enzymes of the urea cycle
[NAME] trioleate and glyceryl trierucate |  | Treatment of adrenoleukodystrophy.
Glycopyrrolate |  | Treatment of pathologic (chronic moderate to severe) drooling in pediatric patients
GMI-1070 |  | Treatment of vaso-occlusive crisis in patients with sickle cell disease.
GNE [NAME] |  | Treatment of hereditary inclusion body myopathy-2
Golimumab |  | Treatment of chronic sarcoidosis
[NAME] |  | Treatment of cancer of the adrenal cortex.
Gp100 adenoviral gene therapy |  | Treatment of metastatic melanoma.
[NAME] colony stimuling factor |  | Treatment of cystic fibrosis
[NAME] macrophage-colony stimulating factor | Leucomax | Treatment of severe thermal injuries in patients with greater than 40% full or partial thickness burns.
[NAME] macrophage-colony stimulating factor | Leucomax | Treatment of chronic lymphocytic leukemia to increase granulocyte count.
[NAME] macrophage-colony stimulating factor | Leucomax | Treatment of myelodysplastic syndrome.
[NAME] macrophage-colony stimulating factor | Leucomax | Treatment of neutropenia associated with bone marrow transplants.
[NAME] macrophage-colony stimulating factor | Leucomax | Treatment of neutropenia due to hairy cell leukemia.
Group B streptococcus immune globulin |  | Treatment of neonates for disseminated group B streptococcal infection.
Growth hormone releasing factor |  | For the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
Guanethidine monosulfate | Ismelin | Treatment of moderate to severe reflex sympathetic dystrophy and causalgia.
Guanfacine | Tenex | Treatment of fragile X syndrome.
Gusperimus | Spanidin | Treatment of acute renal graft rejection episodes.
Halofuginone | Stenorol | Treatment of systemic sclerosis.
heat killed Mycobacterium w immunomodulator | CADI Mw | Active tuberculosis
heat killed mycobacterium w immunomodulator | CADI Mw | Adjuvant to multi-drug therapy in the management of multibacillary leprosy
Heme arginate | [NAME] | Treatment of symptomatic stage of acute porphyria.
Heme arginate | [NAME] | Treatment of myelodysplastic syndromes.
Hemin and zinc mesoporphyrin | Hemex | Treatment of acute porphyric syndromes.
Hemoximer (pyridoxalated hemoglobin polyoxyethylene) |  | Treatment of cardiogenic shock
Heparin |  | Treatment of cystic fibrosis
Heparin sodium |  | Treatment of cystic fibrosis
Heparin-binding epidermal growth factor-like growth factor |  | Prevention and treatment of necrotizing enterocolitis (NEC) in preterm infants with birth weight less than 1,500 grams
Hepatitis B immune globulin intravenous (human) | Nabi-HB | Prophylaxis against hepatitis B virus reinfection in liver transplant patients.
Hepatitis C virus immune globulin (human) | Civacir(tm) | Prophylaxis of hepatitis C infection in liver transplant recipients.
HepeX-B |  | For the prevention of hepatitis B virus (HBV) reinfection in patients who have received a liver transplantation
Herpes simplex virus gene |  | Treatment of primary and metastatic brain tumors.
Histamine | Maxamine | For use as an adjunct to cytokine therapy in the treatment of malignant melanoma.
Histamine | [NAME] | Adjunct to cytokine therapy in the treatment of acute myeloid leukemia.
Histrelin |  | Treatment of acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria.
HIV neutralizing antibodies | Immupath | Treatment of acquired immunodeficiency syndrome.
HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex | [NAME] | Treatment of invasive and metastatic melanoma (Stages II, III, and IV).
homoharringtonine |  | Treatment for chronic myelogenous leukemia
HPA-23 |  | Treatment of acquired immunodeficiency syndrome.
HPV-16 cancer therapeutic trojan peptide vaccine |  | Treatment of HPV-16 expressing head and neck squamous cell carcinoma.
Hsp E7 |  | Treatment of recurrent respiratory papillomatosis (RRP)
Hu1D10, humanized monoclonal antibody | Remitogen | For use in the treatment of 1D10+ B cell [NAME] lymphoma
Human acid precursor alpha-glucosidase, recombinant |  | Treatment of glycogen storage disease type II.
Human alpha 2,6 sialyltransferase adenoviral gene therapy |  | Treatment of patients with invasive (malignant) brain and central nervous system tumors lacking alpha 2,6 sialyltransferase.
Human anti-CD30 monoclonal antibody |  | Treatment of Hodgkin's disease
human anti-CD4 monoclonal antibody | HuMax-CD4 | Treatment of mycosis fungoides
human anti-cellular adhesion molecule-1 monoclonal antibody |  | Treatment of multiple myeloma
Human [NAME] receptor [NAME] antibody |  | Treatment of patients with angiosarcoma
human anti-integrin receptor [NAME]/avb5 monoclonal antibody |  | Treatment of patients with high-risk stage II, stage III, and stage IV malignant melanoma
human anti-transforming growth factor beta 1 monoclonal antibody |  | Treatment of systemic sclerosis
human anti-transforming growth factor-B1,2,3 |  | Treatment of idiopathic pulmonary fibrosis
Human autologous bone-forming cell derived from bone marrow stem cells |  | Treatment of osteonecrosis
human coagulation factor [NAME] | Hemoleven | Treatment of severe congential Factor XI deficiency.
Human cytomegalovirus immunoglobulin |  | Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women
Human factor X |  | Treatment of hereditary factor X deficiency
human gammaglobulin |  | Treatment of gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism in pediatric patients.
human gammaglobulin |  | Treatment of idiopathic inflammatory myopathies
human gammaglobulin |  | Treatment for juvenile rheumatoid arthritis
Human IgM monoclonal antibody (C-58) To CMV | Centovir | Prophylaxis of cytomegalovirus infections in bone marrow transplant patients.
Human IgM monoclonal antibody (C-58) To CMV | Centovir | Treatment of cytomegalovirus infections in allogenic bone marrow transplant patients.
Human immune globulin | Xepol | Treatment of post-polio syndrome
Human immunodeficiency virus immune globulin |  | Treatment of AIDS.
Human immunodeficiency virus immune globulin |  | Treatment of HIV-infected pregnant women and infants of HIV-infected mothers.
Human immunodeficiency virus immune globulin | Hivig | Treatment of HIV-infected pediatric patients.
Human [NAME]-CD30 monoclonal antibody |  | Treatment of CD30+ T-cell lymphoma
Human immunoglobulin (IgG1k)antiCTLA-4 monoclonal antibody |  | Treatment of high risk Stage II, Stage III, and Stage IV melanoma
human leukocyte-derived cytokine mixture |  | Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck
Human monoclonal antibody against platelet-derived growth factor D |  | To slow the progression of IgA nephropathy and delay kidney failure in patients affected by the disease.
Human monoclonal antibody directed against serotype 011 Pseudomonas aeruginosa | Aerumab 11 | Treatment of hospital acquired pneumonia caused by serotype 011 positive Pseudomonas aeruginosa
Human monoclonal antibody of the Ig1/k-isotype against human interleukin-1 beta |  | Treatment of cryopyrin-associated periodic syndromes
Human monoclonal antibody targeting CC-chemokine ligand 2 |  | Treatment of pancreatic cancer
Human plasma coagulation Factor VIII and human plasma von Willebrand Factor | Wilate | Treatment of von Willebrand disease except for surgical and/or invasive procedures in patients with [NAME] disease in whom desmopressin is either ineffective or contraindicated
Human [NAME] complex concentrate | [NAME] | Reversal of anticoagulation therapy in patients needing treatment of serious or life threatening bleeding and/or needing urgent surgery or invasive procedures
human recombinant fusion protein |  | Treatment of hypophosphatasia
Human telomerase reverse transcriptase peptide vaccine |  | Treatment of pancreatic cancer
Human T-lymphotropic virus type III Gp160 antigens | [NAME] | Treatment of AIDS.
Human umbilical tissue-derived cells |  | Treatment of retinitis pigmentosa
Humanized anti-CD2 monoclonal antibody |  | Treatment of graft-versus-host disease.
Humanized anti-CD3 monoclonal antibody |  | Treatment of recent-onset Type I diabetes
humanized anti-human CD16 monoclonal antibody |  | Treatment of adult idiopathic thrombocytopenic purpura
Humanized anti-human CD2 MAb | MEDI-507 | For the induction of donor-specific immunologic unresponsiveness resulting in prophylaxis of organ rejection without the need for chronic immunosuppressive therapy, in patients receiving allogeneic renal transplants.
Humanized anti-tac | Zenapax | Prevention of acute graft-vs-host disease following bone marrow transplantation.
humanized IgG2 antibody |  | Treatment of vaso-occlusive crisis in patients with sickle cell disease.
[NAME] (IDEC-131) to CD40L |  | Treatment of systemic lupus erythematosus.
humanized monoclonal antibody against Shiga-like toxin II |  | To prevent the development of or to decrease the incidence and severity of hemolytic uremic syndrome and associated sequelae of  Shiga-like toxin-producing E. coli.
Humanized monoclonal antibody to the high affinity folate alpha receptor |  | Treatment of ovarian cancer
humanized monocloncal antibody against human [NAME] |  | Treatment of fibrosis-associated chronic allograft nephropathy in kidney transplant patients.
hyaluronic acid |  | Treatment of emphysema in patients due to alpha-1 antitrypsin deficiency
Hydralazine |  | Treatment of severe intrapartum hypertension (diastolic blood pressure greater than or equal to 110 or systolic blood pressure greater than or equal to 160) associated with severe preeclampsia/eclampsia of pregnancy
hydrocortisone modified release tabs | DuoCort | Treatment of adrenal insufficiency
Hydroxocobalamin |  | Treatment of acute cyanide poisoning
Hydroxycobalamin/sodium thiosulfate |  | Treatment of severe acute cyanide poisoning.
hydroxyurea |  | Treatment of pediatric patients with sickle cell anemia.
Hypericin |  | Treatment of glioblastoma multiforme.
Hypericin |  | Treatment of cutaneous T-cell lymphoma.
I(131)-TM-601 (chlorotoxin) |  | Treatment of malignant glioma
Iboctadekin |  | Treatment of renal cell carcinoma
Ibuprofen i.v. solution | Salprofen | Prevention of patent ductus arteriosus.
icatibant |  | Treatment of burn patients hospitalized with burn-induced edema
icatibant |  | Treatment of angioedema
Idarubicin | Idamycin | Treatment of chronic myelogenous leukemia.
Idarubicin | Idamycin | Treatment of myelodysplastic syndromes.
Idarubicin HCl for injection | Idamycin | Treatment of acute lymphoblastic leukemia in pediatric patients.
idebenone |  | Treatment of Leber's hereditary optic neuropathy.
idebenone |  | Treatment of [NAME] muscular dystrophy
Idebenone |  | Treatment of Friedreich's ataxia
Idoxuridine |  | Treatment of nonparenchymatous sarcomas.
IDUA-HIRMAb fusion protein | AGT-181 | Treatment of mucopolysaccharidosis Type 1 (MPS)
Ifosfamide | [NAME] | Treatment of bone sarcomas
Ifosfamide | [NAME] | Treatment of soft tissue sarcomas.
IL13-PE38QQR |  | Treatment of malignant glioma
IL-4 Pseudomonas Toxin Fusion Protein (IL-4(38-37)-PE38KDEL) |  | Treatment of astrocytic glioma.
Iloprost solution for infusion |  | Treatment of [NAME]'s phenomenon secondary to systemic sclerosis.
Iloprost solution for infusion |  | Treatment of heparin-associated thrombocytopenia.
[NAME] pentetate | Myoscint | Detecting early necrosis as an indication of rejection of orthotopic cardiac transplants.
imexon | Amplimexon | Treatment of ovarian cancer.
Imexon |  | Treatment of multiple myeloma.
Imexon |  | Treatment of pancreatic adenocarcinoma
Imexon |  | Treatment of metastatic malignant melanoma
Immortalized human liver cells found in the extracorporeal liver assist device | ELAD | Treatment of fulminant hepatic failure (acute liver failure)
Immune Globulin (Human) containing high titers of West Nile virus antibodies | [NAME] (tm)  5% (WNV) | Treatment of the West Nile virus infection
Immune Globulin Intravenous (human) | Carimune NF | Treatment for Guillain Barre Syndrome
Immune globulin intravenous (human) | Gammagard Liquid | Treatment of multifocal motor neuropathy
Immune globulin intravenous (human) | Immune Globulin Intravenous (human) [NAME], Iveegam | Treatment of patients with acute myocarditis.
Immune globulin intravenous (human) | Iveegam, [NAME] | Treatment of polymyositis/dermatomyositis.
Immune globulin intravenous (human) | Iveegam, [NAME] | Treatment of juvenile rheumatoid arthritis.
Immune Globulin Subcutaneous (Human) | Vivaglobin P (proposed) | Treatment of patients with primary immune deficiency (PID) that are intolerant to immune globulin intravenous (IGIV) due to severe adverse events or poor venous access
Implitapide |  | Treatment of homozygous familial hypercholesterolemia
Implitapide |  | Treatment of patients with Fredrickson type I or V hyperlipoproteinemia
Imported fire ant venom, allergenic extract |  | For skin testing of victims of fire ant stings to confirm fire ant sensitivity and if positive, for use as immunotherapy for the prevention of IgE-mediated anaphylactic reactions.
Inalimarev and falimarev |  | Treatment of adenocarcinoma of the pancreas
Indium In 111 murine monoclonal antibody FAB to [NAME] | Myoscint | To aid in the diagnosis of myocarditis.
Indium In-111 altumomab pentetate | Hybri-ceaker | Detection of suspected and previously unidentified tumor foci of recurrent colorectal carcinoma.
Indium-111 pentetreotide | NeuroendoMedix | Treatment of neuroendocrine tumors
[NAME] | Remicade | Treatment of juvenile rheumatoid arthritis
[NAME] | Remicade | Treatment of giant cell arteritis
[NAME] | REMICADE | Treatment of pediatric (0 to 16 years of age) ulcerative colitis
[NAME] | Remicade | Treatment of chronic sarcoidosis
INGN 201 | ADVEXIN | Treatment of  head and neck cancer
INH-A00021 | Veronate | Reduction (prevention) of nosocomial bacteremia caused by staphylococci in very low birth weight infants.
[NAME] | Leukotac | Treatment of graft versus host disease
Inosine pranobex | Isoprinosine | Treatment of subacute sclerosing panencephalitis.
Interferon alfa-2a (recombinant) | Roferon-A | Treatment of renal cell carcinoma.
Interferon alfa-2a (recombinant) | Roferon-A | For the treatment of metastatic malignant melanoma in combination with Teceleukin.
Interferon alfa-2a (recombinant) | Roferon-A | For the concomitant administration with [NAME] for the treatment of metastatic renal cell carcinoma.
Interferon alfa-2a (recombinant) | Roferon-A | For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer.
Interferon alfa-2a (recombinant) | Roferon-A | For use in combination with fluorouracil for the treatment of esophageal carcinoma.
Interferon alfa-2b (recombinant) | Intron A | Treatment of acute hepatitis B.
Interferon alfa-2b (recombinant) | Intron A | Treatment of primary malignant brain tumors.
Interferon alfa-2b (recombinant) | Intron A | Treatment of carcinoma in situ of the urinary bladder.
Interferon alfa-2b (recombinant) | Intron A | Treatment of invasive carcinoma of the cervix.
Interferon alfa-2b (recombinant) | Intron A | Treatment of ovarian carcinoma.
Interferon alfa-2b (recombinant) | Intron A | Treatment of chronic myelogenous leukemia.
Interferon alfa-2b (recombinant) | Intron A | Treatment of metastatic renal cell carcinoma.
Interferon alfa-2b (recombinant) | Intron A | Treatment of laryngeal (respiratory) papillomatosis.
Interferon alfa-2b (recombinant) | Intron A | Treatment of chronic delta hepatitis.
Interferon alfa-nl | Wellferon | Treatment of human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis.
Interferon alfa-nl | Wellferon | Treatment of AIDS related Kaposi's sarcoma.
Interferon beta (recombinant) | R-IFN-beta | For the systemic treatment of metastatic renal cell carcinoma.
Interferon beta (recombinant) | r-HuIFN-beta | For the intralesional and/or systemic treatment of AIDS-related Kaposi's sarcoma.
Interferon beta (recombinant) | r-HuIFN-beta | For the systemic treatment of cutaneous T-cell lymphoma.
Interferon beta, recombinant human | Betaseron | Treatment of acquired immunodeficiency syndrome.
Interferon beta-1a | [NAME] | Treatment of patients with secondary progressive multiple sclerosis.
interferon Beta-1a | Avonex | Treatment of juvenile rheumatoid arthritis.
Interferon beta-1a (recombinant human) |  | Treatment of acute non-A, non-B hepatitis.
Interferon beta-1a (recombinant) | r-HuIFN-beta | For the systemic treatment of cutaneous malignant melanoma.
Interferon beta-1a (recombinant) | [NAME] | Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.
Interferon gamma |  | Treatment of idiopathic pulmonary fibrosis
[NAME] | Actimmune | Treatment of idiopathic pulmonary fibrosis
Interferon gamma-1b | Actimmune | Treatment of renal cell carcinoma.
Interferon-alfa-1b |  | Treatment of multiple myeloma
Interleukin-1 alpha, human recombinant |  | For hematopoietic potentiation in aplastic anemia.
Interleukin-1 alpha, human recombinant |  | For the promotion of early engraftment in bone marrow transplantation.
Interleukin-1 receptor antagonist, human recombinant | Antril | Treatment of juvenile rheumatoid arthritis.
Interleukin-1 receptor antagonist, human recombinant | Antril | Prevention and treatment of graft versus host disease in transplant recipients.
Interleukin-1 Trap |  | Treatment of Still's disease including juvenile rheumatoid arthritis and adult-onset Still's disease
Interleukin-2 | [NAME] | In combination with interferon alfa-2a for the treatment of metastatic malignant melanoma.
Interleukin-2 | Teleleukin | Treatment of metastatic malignant melanoma.
Interleukin-2 | [NAME] | Treatment of metastatic renal cell carcinoma.
Interleukin-2 | [NAME] | In combination with interferon alfa-2a for the treatment of metastatic renal cell carcinoma.
Interleukin-3 human (recombinant) |  | Promotion of erythropoiesis in Diamond-Blackfan anemia (congenital pure red cell aplasia).
[NAME], human, recombinant |  | For sequential administration with sargramostim to accelerate neutrophil and platelet recovery in patients undergoing autologous bone marrow transplantation for the treatment of [NAME]'s disease or non-Hodgkin's lymphoma.
Intraoral fluoride releasing system | IFRS | Prevention of dental caries due to radiation-induced xerostomia in patients with head and neck cancer
Intravenous immune globulin | VitiGam | Treatment of Stage IIB to IV malignant melanoma
Intravenous immune globulin (human) 10% | Octagam | Treatment of stiff-person syndrome
iobenguane I 131 |  | Treatment of neuroendocrine tumors
Iobenguane I 131 | [NAME] | Treatment of neuroendocrine tumors
Iobenguane Sulfate I-123 | OmaClear | For scintigraphic detection, localization and staging of neuroblastoma.
iobenguane sulfate I-123 | OmaClear | For the detection, localization, and staging of pheochromocytomas.
Iodine 131 6B-iodomethyl-19-norcholesterol |  | For use in adrenal cortical imaging.
Iodine I 123 murine monoclonal antibody to alpha-fetoprotein |  | Detection of alpha-fetoprotein producing germ cell tumors.
Iodine I 123 murine monoclonal antibody to alpha-fetoprotein |  | Detection of hepatocellular carcinoma and hepatoblastoma.
Iodine I 123 murine monoclonal antibody to hCG |  | Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.
Iodine I 131 bis(indium-diethylenetriaminepentaacetic acid)tyrosyllysine/hMN-14 x m734 F(ab')2 bispecific monoclonal antibody | Pentacea | Treatment of small-cell lung cancer.
Iodine I 131 Lym-1 [NAME] |  | Treatment of B-cell lymphoma.
Iodine I 131 murine monoclonal antibody IgG2a to B cell | Immurait, Ll-2-I-131 | Treatment of B-cell leukemia and B-cell lymphoma.
Iodine I 131 murine monoclonal antibody to alpha-fetoprotein |  | Treatment of alpha-fetoprotein producing germ cell tumors.
Iodine I 131 murine monoclonal antibody to alpha-fetoprotein |  | Treatment of hepatocellular carcinoma and hepatoblastoma.
Iodine I 131 murine monoclonal antibody to hCG |  | Treatment of hCG producing tumors such as germ cell and trophoblastic cell tumors.
Iodine I-131 radiolabeled chimeric [NAME] necrosis treatment (TNT-1B) | 131IchTNT-1 | Treatment of glioblastoma multiforme and anaplastic astrocytoma.
irofulven |  | Treatment of renal cell carcinoma.
irofulven |  | Treatment of ovarian cancer.
Isobutyramide |  | Treatment of sickle cell disease and beta thalassemia.
Isobutyramide | Isobutyramide oral solution | Treatment of beta-hemoglobinopathies and beta-thalassemia syndromes.
isofagomine tartrate |  | Treatment of Gaucher disease
Itraconazole suspension |  | Topical treatment of fungal otitis externa (otomycosis)
IV Sotalol | So-Aqueous | For [NAME], ventricular fibrillation, or the maintenance of sinus rhythm in patients converted from atrial fibrillation or atrial flutter when oral administration is not possible.
JAK tyrosine kinase inhibitor |  | Treatment of myelofibrosis
Japanese encephalitis vaccine (live, attenuated) |  | Prevention of Japanese encephalitis.
Ketoconazole | Nizoral | For use with cyclosporine A to diminish the nephrotoxicity induced by cyclosporine in organ transplantation.
kit for the preparation of technetium Tc99m sulfur colloid |  | For localization of sentinel lymph nodes in patients with melanoma.
L-2-oxothiazolidine-4-carboxylic acid | Procysteine | Treatment of adult respiratory distress syndrome.
L-2-oxothiazolidine-4-carboxylic acid | Procysteine | Treatment of amyotrophic lateral sclerosis.
[NAME] |  | Treatment of tetrahydrobiopterin deficiency.
Lactic acid | Aphthaid | Treatment of severe aphthous stomatitis in severely, terminally immunocompromised patients.
lactic acid bacteria (Lactobacilli, Bifidobacteria, and Steptococci) |  | Treatment of active chronic pouchitis
lactic acid bacteria (Lactobacilli, Bifidobacteria, and Streptococcus species) |  | Prevention of disease relapse in patients with chronic pouchitis
[NAME] | [NAME] | Treatment of AIDS-associated diarrhea unresponsive to initial antidiarrheal therapy.
L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal |  | Treatment of [NAME] and Becker muscular dystrophy
laromustine | Onrigin | Treatment of acute myelogenous leukemia
Latrodectus immune F(ab)2 | Aracmyn | Treatment of black widow spider envenomations
L-baclofen |  | Treatment of trigeminal neuralgia.
L-Baclofen | Neuralgon | Treatment of intractable spasticity in children with cerebral palsy.
L-baclofen | Neuralgon | Treatment of intractable spasticity associated with spinal cord injury or multiple sclerosis.
L-Baclofen |  | Treatment of trigeminal neuralgia.
L-cycloserine |  | Treatment of Gaucher's disease.
L-cysteine |  | For the prevention and lessening of photosensitivity in erythropoietic protoporphyria.
Leflunomide |  | Prevention of acute and chronic rejection in patients who have received solid organ transplants.
lenalidomide | Revlimid(r) | Treatment of mantle cell lymphoma
lenalidomide | Revlimid | Treatment of chronic lymphocytic leukemia.
Lentiviral vector encoded with a human beta-globin gene plasmid | Thalagen | Treatment of beta-thalassemia major and beta-thalassemia intermedia
Lestaurtinib |  | Treatment of acute myeloid leukemia
Leucovorin calcium | Wellcovorin | For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer.
[NAME] | Multikine | Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck
Leupeptin |  | For use as an adjunct to microsurgical peripheral nerve repair.
[NAME] HCl ophthalmic suspension 0.05% |  | Treatment of vernal keratoconjunctivitis.
Levocarnitine | Carnitor | Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis.
Levocarnitine | Carnitor | For the treatment of secondary carnitine deficiency in valproic acid toxicity.
Levocarnitine | Carnitor | For the prevention of secondary carnitine deficiency in valproic acid toxicity.
Levocarnitine | Carnitor | Treatment of zidovudine-induced mitochondrial myopathy.
Levocarnitine | Carnitor | Treatment of pediatric cardiomyopathy.
Levodopa and carbidopa | Duodopa | Treatment of late stage Parkinson's disease.
[NAME] |  | Treatment of pulmonary infections due to Pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis patients
L-glutamine |  | Treatment of sickle cell disease
L-glutamyl-L-tryptophan |  | Treatment of AIDS-related Kaposi's sarcoma.
liarozole |  | The treatment of congenital ichthyosis
[NAME] |  | Treatment of myelodysplastic syndrome
[NAME] |  | Treatment of acute myeloid leukemia.
[NAME] | Zamyl | Treatment of acute myelogenous leukemia
Lipid/DNA human cystic fibrosis gene |  | Treatment of cystic fibrosis.
Liposomal amphotericin B | AmBisome | Treatment of histoplasmosis.
Liposomal annamycin |  | Treatment of acute myeloid leukemia
Liposomal annamycin |  | Treatment of acute lymphoblastic leukemia
Liposomal ciprofloxacin |  | Management of bronchiectasis
Liposomal ciprofloxacin for inhalation |  | Management of cystic fibrosis
Liposomal cisplatin | LipOva-Pt | Treatment of ovarian cancer
Liposomal cyclosporin A | Cyclospire | For aerosolized administration in the prevention and treatment of lung allograft rejection  and pulmonary rejection events associated with bone marrow transplantation.
liposomal cyclosporine for inhalation |  | Prevention of bronchiolitis obliterans.
Liposomal doxorubicin hydrochloride | Sarcodoxome | Treatment of soft tissue sarcomas
liposomal gadodiamide |  | Treatment of glioma.
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl | ImmTher | Treatment of osteosarcoma.
Liposomal N-Acetylglucosminyl-N-Acetylmuramly-L-Ala-D-isoGln-L-Ala -gylcerolidpalmitoyl | ImmTher | Treatment of Ewing's sarcoma.
Liposomal nystatin | Nyotran | Treatment of invasive fungal infections.
liposomal p-ethoxy growth receptor bound protein-2 antisense product |  | Treatment of chronic myelogenous leukemia
Liposomal prostaglandin E1 injection |  | Treatment of acute respiratory distress syndrome.
liposomal topotecan hydrochloride |  | Treatment of gliomas
Liposomal-cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane-Pt (II) | Aroplatin | Treatment of malignant mesothelioma.
Liposome encapsulated recombinant interleukin-2 |  | Treatment of brain and CNS tumors.
Liposome encapsulated recombinant interleukin-2 |  | Treatment of cancers of the kidney and renal pelvis
Lisofylline |  | Treatment of patients undergoing induction therapy for acute myeloid leukemia.
L-leucovorin | Isovorin | For use in combination chemotherapy with the approved agent 5-fluorouracil in the  palliative treatment of metastatic adenocarcinoma of the colon and rectum.
[NAME] |  | Treatment of common variable immunodeficiency.
L-threonine |  | Treatment of spasticity associated with familial spastic paraparesis.
L-threonine | Threostat | Treatment of amyotrophic lateral sclerosis.
L-threonyl-L-prolyl-L-prolyl-L-threonine |  | Treatment of neuropathic pain associated with spinal cord injury
L-tyrosine-L-serine-L-leucine | CMS-024 | Treatment of hepatocellular carcinoma.
Lucinactant | Surfaxin | Prevention of bronchopulmonary dysplasia in premature infants
Lucinactant | Surfaxin | Treatment of bronchopulmonary dysplasia in premature infants.
Lucinactant | Surfaxin | Treatment of meconium aspiration syndrome in newborn infants
Lucinactant | Surfaxin | Treatment of acute respiratory distress syndrome in adults.
Lucinactant | Surfaxin | Treatment of respiratory distress syndrome in premature infants.
Lysine acetylsalicylate injectable |  | Treatment of pain and fever secondary to sickle cell disease crisis.
lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase |  | Treatment of mucopolysaccharidosis Type IVA (Morquio Syndrome)
lyso-thermosensitive lipsomal doxorubicin | ThermoDox (r) | For treatment of hepatocellular carcinoma.
macitentan |  | Treatment of idiopathic pulmonary fibrosis.
Mafosfamide |  | Treatment of neoplastic meningitis
MAGE-A3 cancer therapeutic [NAME] peptide vaccine |  | Treatment of MAGE-A3 expressing head and neck squamous cell carcinoma
Mammalian target of rapamcyin (mTOR) inhibitor |  | Treatment of soft tissue sarcoma
Manganese superoxide dismutase mimetic |  | Prevention of radiation- or chemotherapy-induced oral mucositis in cancer patients
[NAME] | Bronchitol | For use to facilitate clearance of mucus in patients with bronchiectasis and in patients with cystic fibrosis at risk for bronchiectasis
mannopentaose phosphate sulfate |  | Treatment of high-risk Stage II, Stage III, and Stage IV melanoma
maribavir |  | Prevention of cytomegalovirus viremia and disease in the populations at risk.
[NAME] |  | Treatment of HIV-associated wasting syndrome.
Matrix metalloproteinase inhibitor | Galardin | Treatment of corneal ulcers.
MaxAdFVIII |  | Treatment of  Hemophilia A
[NAME] | Sanorex | Treatment of [NAME] muscular dystrophy.
Mecamylamine | Inversine | Treatment of Tourette's syndrome.
mecasermin | Iplex | Treatment of myotonic dystrophy
Mecasermin | Myotrophin | Treatment of amyotrophic lateral sclerosis.
meclorethamine or nitrogen mustard |  | Treatment of mycosis fungoides.
MEDI-522 | Vitaxin | For the treatment of of stage IIb, stage IIc, stage III and stage IV melanoma
Medroxyprogesterone acetate | Hematrol | Treatment of immune thrombocytopenic purpura.
Mefloquine HCl | Mephaquin | Prevention of chloroquine-resistant Falciparum malaria.
Mefloquine HCl | Mephaquin | Treatment of chloroquine-resistant Falciparummalaria.
Melanoma autologous dendritic cell vaccine |  | Treatment of stage IIIb through IV metastatic melanoma
Melanoma cell vaccine | Canvaxin | Treatment of invasive melanoma.
Melanoma peptide vaccine |  | Treatment of HLA-A2+ patients with stage  IIB, IIC, III, and IV malignant melanoma
Melanoma vaccine | [NAME] | Treatment of stage III - IV melanoma.
Melatonin | [NAME] | Treatment of non-24-hour sleep-wake disorder in blind individuals without light perception
Melatonin |  | Treatment of circadian rhythm sleep disorders in blind people with no light perception.
melphalan |  | High dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation
Melphalan | Alkeran for Injection | For use in hyperthermic regional limb perfusion to treat metastatic melanoma of the extremity.
melphalan hydrochloride |  | Treatment of patients with ocular (uveal) melanoma.
melphalan hydrochloride |  | Treatment of patients with cutaneous melanoma.
mepivacaine |  | Treatment of postherpetic neuralgia
Mepivacaine |  | Treatment of painful HIV-associated neuropathy
mepolizumab |  | For first-line treatment in patients with hypereosinophilic syndrome
Meropenem | [NAME] | Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.
mesalamine; 5-aminosalicylic acid | [NAME] | Treatment of active, mild to moderate ulcerative colitis in children 5 to 17 years
Mesna |  | Inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide.
Methionine/L-methionine |  | Treatment of AIDS myelopathy.
methotrexate | Rheumatrex | Treatment of juvenile rheumatoid arthritis.
Methotrexate with laurocapram | Methotrexate/azone | Topical treatment of mycosis fungoides.
Methoxsalen | Uvadex | For use in conjunction with the UVAR photopheresis system to treat graft versus host disease.
metreleptin |  | Treatment of metabolic disorders secondary to lipodystrophy
metreleptin |  | Treatment of leptin deficiency secondary to generalized lipodystrophy and partial familial lipodystrophy
metronidazole |  | Treatment of pouchitis
Metronidazole | [NAME] | Treatment of perioral dermatitis.
Metronidazole (topical) | Flagyl | Treatment of grade III and IV, anaerobically infected, decubitus ulcers.
Metronidazole 10% ointment |  | Topical treatment of active perianal Crohn's disease
metyrosine | Demser | Treatment of velocardiofacial syndrome associated psychosis.
mibefradil |  | Treatment of pancreatic cancer.
Mibefradil |  | Treatment of ovarian cancer
Microbubble contrast agent | Filmix Neurosonographic Contrast Agent | Intraoperative aid in the identification and localization of intracranial tumors.
Microvesiculated modified glycosylated tissue factor |  | Treatment of cutaneous bleeding episodes in patients with [NAME] disease.
Microvesiculated modified glycosylated tissue factor |  | Treatment of non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in hemophiliac patients
[NAME] HCl |  | Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam
mifamuritide | [NAME] | Treatment of osteosarcoma
Mifepristone |  | Treatment of Cushing's syndrome secondary to ectopic ACTH secretion
mifepristone | Corlux | Treatment of the clinical manifestations of endogenous Cushing's symdrome.
miglustat | Zavesca (r) | Treatment of the neurological manifestations of Niemann-Pick disease,type C.
milatuzumab |  | Treatment of chronic lymphocytic leukemia.
milatuzumab |  | Treatment of multiple myeloma
miltefosine | Miltex(r)  /  Impavido(r) | Topical treatment of cutaneous lymphoma encompassing cutaneous manifestations of T-cell lymphoma and B-cell lymphoma
miltefosine | Impavido | Treatment of leishmaniasis.
Minocycline HCl | [NAME] | Treatment of chronic malignant pleural effusion.
Minocycline hydrochloride |  | Treatment of sarcoidosis
[NAME] | GyMiso | Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy.
Mitoguazone | apep | Treatment of diffuse [NAME] lymphoma, including AIDS-related diffuse [NAME] lymphoma.
Mitolactol |  | Treatment of invasive carcinoma of the uterine cervix
Mitolactol |  | As adjuvant therapy in the treatment of primary brain tumors.
mitomycin-C | Trabomycin | Treatment of refractory glaucoma as an adjunct to ab externo glaucoma surgery.
Mitomycin-C |  | Treatment of refractory glaucoma as an adjunct to ab externo glaucoma surgery.
MN14 monoclonal antibody to carcinoembryonic antigen | [NAME] | Treatment of small cell lung cancer
MN14 monoclonal antibody to carcinoembryonic antigen | [NAME] | Treatment of pancreatic cancer.
Molgramostim | Leucomax | Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir.
Molgramostim | Leucomax | Treatment of aplastic anemia.
monarsen |  | Treatment of Myasthenia Gravis
Monoclonal Ab(murine) anti-idiotype melanoma-associated antigen | Melimmune | Treatment of invasive cutaneous melanoma.
Monoclonal antibodies (murine or human) to B-cell lymphoma |  | Treatment of B-cell lymphoma.
Monoclonal antibody 17-1a | Panorex | Treatment of pancreatic cancer.
monoclonal antibody 3F8 |  | Treatment of neuroblastoma
Monoclonal antibody for immunization against lupus nephritis |  | Treatment of lupus nephritis.
Monoclonal antibody to cytomegalovirus (human) |  | Treatment of cytomegalovirus retinitis in patients with AIDS.
Monoclonal antibody to cytomegalovirus (human) |  | Prophylaxis of cytomegalovirus disease in patients undergoing solid organ transplantation.
Monoclonal antibody to hepatitis B virus (human) |  | Prophylaxis of hepatitis B reinfection in patients undergoing liver transplantation secondary to end-stage chronic hepatitis B infection.
Monoclonal antibody-B43.13 | Ovarex MAb-B43.13 | Treatment of epithelial ovarian cancer.
Monoclonal antiendotoxin antibody XMMEn-0e5 |  | Treatment of patients with gram-negative sepsis which has progressed to shock.
Monolaurin | [NAME] | Treatment of congenital primary ichthyosis.
motexafin gadolinium | Xcytrin | For use in conjunction with whole brain radiation for the treatment of brain metastases arising from solid tumors
MTC-DOX for Injection |  | Treatment of hepatocellular carcinoma
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin | MEP IGIV | Treatment of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
Mucoid exopolysaccharide Pseudomonas hyperimmune globulin | MEP IGIV | Prevention of pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
Multi-ligand somatostatin analogue |  | Treatment of patients with functional gastroenteropancreatic (GEP) neuroendocrine tumors (specifically, carcinoid, insulinoma, gastrinoma, somastatinoma, GRFoma, VIPoma and glucagonoma.
Multi-vitamin infusion (neonatal formula) |  | For establishment and maintenance of total parenteral nutrition in very low birth weight infants.
[NAME] (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma | Oncolym | Treatment of B-cell non-Hodgkin's lymphoma.
[NAME] to polymorphic epithelial mucin, human milk fat globule 1 | Theragyn | Adjuvant treatment of ovarian cancer.
Mx-dnG1 | [NAME]) | Treatment for soft tissue sarcoma.
Mx-dnG1 | [NAME] | Treatment of osteosarcoma.
Mx-dnG1 or [NAME] retroviral vector | REXIN-G | Treatment of pancreatic cancer
Mycobacterium avium sensitin RS-10 |  | For use in the diagnosis of invasive Mycobacterium avium disease in immunocompetent individuals.
Mycophenolate mofetil | CellCept | Treatment of pemphigus vulgaris
[NAME] |  | Treatment of multiple sclerosis.
myo-inositol |  | Prevention of retinopathy of prematurity in preterm infants at risk for developing retinopathy of prematurity
myristoylated recombinant SCR1-3 of human complement reseptor type I | APT070 | Prevention of delayed graft function in solid organ transplant
N-((methyl-diazacyclohexyl-methylbenzamide)-asaphenyl-aminothiopyrrole) mesylate |  | Treatment of malignant gastrointestinal stromal tumors.
N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'biphenyl]-2-yl]carbonyl]amino]-1-piperidinyl]butyl]-9H-fluorene-9-carboxamide, methane-sulfonate salt |  | Treatment of homozygous familial hypercholesterolemia
N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide, phosphate (1:2) |  | Treatment of gastrointestinal stromal tumors
N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide |  | Treatment of patients with cystic fibrosis.
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide |  | Treatment of Hodgkin's lymphoma
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide dihydrobromide |  | Treatment of acute myeloid leukemia
N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-(morpholin-4-yl)ethoxy) imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt |  | Treatment of acute myeloid leukemia
N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole) mesylate |  | Treatment of multiple myeloma.
N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide |  | Treatment of neuroblastoma
N-[3-(4',5'-bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide |  | Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia.
N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea |  | Treatment of acute myelogenous leukemia
N-[4-(3-amino1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl)urea |  | Treatment of hepatocellular carcinoma
N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide |  | Treatment of stages IIB-IV melanoma
N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide |  | Treatment of cutaneous T-cell lymphoma
N-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-N'-[3,5-bis(trifluoromethyl)phenyl]urea |  | Treatment of sickle cell disease
N2'-Deacetyl-N2'-[4-methyl-4-(oxobuthyldithio)-1-oxopentyl]-maytansine-chimerized anti-CD138 IgG4 Monoclonal Antibody |  | Treatment of multiple myeloma
nabumetone |  | For treatment of pediatric juvenile rheumatoid arthritis.
N-acetylcysteinate Lysine | [NAME] Powder [NAME] | For the management of cystic fibrosis
N-acetylcysteine |  | Treatment of acute liver failure
N-acetyl-glucosamine thiazoline |  | Treatment of adult Tay-Sachs disease
N-acetylprocainamide | Napa | To lower the defibrillation energy requirement sufficiently to allow automatic implantable cardioverter defibrillator therapy in those patients who could otherwise not use the device.
N-acetyl-procainamide |  | Prevention of life-threatening ventricular arrhythmias in patients with documented procainamide-induced lupus.
N-acetyl-sarcosyl-glycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl_L-prolylethylaminde acetate |  | Treatment of soft tissue sarcoma
N-adamantanyl-N'-Geranyl-ethylenediamine |  | Treatment of tuberculosis.
natural human lymphoblastoid interferon-alpha |  | Treatment of polycythemia vera
Natural human lymphoblastoid interferon-alpha |  | Treatment of [NAME]'s disease.
Natural human lymphoblastoid interferon-alpha |  | Treatment of papillomavirus warts in the oral cavity of HIV positive patients.
NDROGE |  | Treatment of postanoxic intention myoclonus.
Nebacumab | Centoxin | Treatment of patients with gram-negative bacteremia which has progressed to endotoxin shock.
Neurotrophin-1 |  | Treatment of motor neuron disease/amyotrophic lateral sclerosis.
[NAME] | Somatrel | Diagnostic measure of the capacity of the pituitary gland to release growth hormone.
Nifedipine |  | Treatment of interstitial cystitis.
Nikkomycin Z |  | Treatment of coccidioidomycosis
nilotinib | Tasigna | Treatment of gastrointestinal stromal tumors.
[NAME] |  | Treatment of glioma
niprisan | Hemoxin | Treatment of sickle cell disease
nitazoxanide | [NAME] | Treatment for intestinal amebiasis
Nitisinone | Orfadin | Treatment of alkaptonuria
nitric oxide | INOmax (r) | Use in combination with a drug delivery device for acute treatment of sickle cell vaso-occlusive crisis (pain crises)
Nitric oxide |  | Diagnosis of sarcoidosis
Nitric oxide | INOmax | To reduce the risk of chronic lung disease in premature neonates
Nitric oxide |  | Treatment of acute respiratory distress syndrome in adults.
Nitroprusside |  | Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.
N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide) |  | Treatment of metastatic melanoma in combination with paclitaxel
N-Methyl-2-[3-[((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]benzamide | Axitinib | Treatment of follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer.
Novel Acting Thrombolytic (NAT) |  | Treatment of peripheral arterial occlusion (PAO)
Nucleic acid aptamer binding to tumor cell nucleolin |  | Treatment of pancreatic cancer
Nucleic acid aptamer binding to tumor cell nucleon |  | Treatment of renal cell carcinoma
NZ-1002 |  | Enzyme replacement therapy in patients with all subtypes of [NAME]
Obatoclax mesylate |  | Treatment of chronic lymphocytic leukemia
Obatoclax mesylate |  | Treatment of myelodysplastic syndrome
Obatoclax mesylate |  | Treatment of myelofibrosis
oblimersen | Genasense | Treatment of acute myelocytic leukemia
oblimersen | Genasense | Treatment of multiple myeloma
oblimersen | Genasense | Treatment of chronic lymphocytic leukemia
oblimersen | Genasense | Treatment of advanced malignant melanoma (Stages II,III, IV).
ofatumumab |  | Treatment of chronic lymphocytic leukemia
oglufanide disodium |  | Treatment of ovarian cancer
OM 401 | Drepanol | Prophylactic treatment of sickle cell disease.
omacetaine mepesuccinate |  | Treatment of myelodysplastic syndromes
Omacetaxine mepesuccinate |  | Treatment of chronic myelogenous leukemia
Omega-3 (n-3) polyunsaturated fatty acid with all double bonds in the cis configuration |  | Prevention of organ graft rejection.
Omega-3 (n-3) polyunsaturated fatty acids | Omacor | Treatment of IgA nephropathy.
Omegaven emulsion | Omegaven | Treatment of parenteral nutrition-associated liver disease
omigapil |  | Treatment of congenital muscular dystrophy.
oncophage |  | Treatment of glioma
Oncorad Ov103 |  | Treatment of ovarian cancer.
oral unfractionated heparin |  | Treatment of sickle cell disease
Orgotein for injection |  | Treatment of familial amyotrophic lateral sclerosis associated with a mutation of the gene (on chromosome 21q) for copper, zinc superoxide dismutase.
[NAME] |  | Treatment of ovarian cancer.
Oxalobacter formigenes |  | Treatment of primary hyperoxaluria
Oxandrolone | Oxandrin | Treatment of short stature associated with Turner's syndrome.
Oxandrolone |  | Treatment of constitutional delay of growth and puberty.
Oxandrolone | Oxandrin | Treatment of patients with [NAME]'s muscular dystrophy and Becker's muscular dystrophy.
Oxandrolone | Oxandrin | Adjunctive therapy for AIDS patients suffering from HIV-wasting syndrome.
Oxandrolone | Hepandrin | Treatment of moderate/severe acute alcoholic hepatitis in the presence of moderate protein calorie malnutrition.
Oxymorphone | [NAME] | For relief of severe intractable pain in narcotic-tolerant patients.
Oxypurinol |  | Treatment of hyperuricemia in patients intolerant to allopurinol.
p1-(uridine 5'-)-p4-(2'-deoxycytidine 5'-) tetraphosphate, tetrasodium salt |  | For the treatment of cystic fibrosis
P1, P4-Di(uridine 5'-tetraphosphate), tetrasodium salt |  | Treatment of cystic fibrosis.
paclitaxel |  | Treatment of pancreatic cancer
Paclitaxel | Paxene | Treatment of AIDS-related Kaposi's sarcoma.
paclitaxel aqueous gel | OncoGel (tm) | Treatment of brain cancer.
paclitaxel aqueous gel | OncoGel(tm) | Treatment of esophageal cancer
paclitaxel, micellar | Paclical | Treatment of ovarian cancer
Pafuramidine maleate |  | Treatment of human African trypanosomiasis (sleeping sickness)
Pafuramidine maleate |  | Treatment of malaria
pafuramidine maleate |  | Treatment of pneumocystis jiroveci pneumonia
Palifosfamide |  | Treatment of soft tissue sarcomas
Panobinostat | Faridak | Treatment of cutaneous T-cell lymphoma
Papain, trypsin, and chymotrypsin | Wobe-Mugos | Treatment of multiple myeloma.
parathyroid hormone |  | Treatment of hypoparathyroidism.
paromomycin sulfate/gentamicin sulfate |  | Treatment of non-complicated Old World cutaneous leishmaniasis
Parvovirus B19 (recombinant [NAME] and VP2; [NAME]) vaccine | MEDI-491 | Prevention of transient aplastic crisis in patients with sickle cell anemia.
Patul-end |  | Treatment of patulous eustachian tube.
Patupilone |  | Treatment of ovarian cancer.
PEG-glucocerebrosidase | Lysodase | For use as chronic enzyme replacement therapy in patients with [NAME]'s disease who are deficient in glucocerebrosidase.
Peginterferon alfa-2a | PEGASYS | Treatment of chronic myelogenous leukemia.
Peginterferon alfa-2a | PEGASYS | Treatment of renal cell carcinoma.
peginterferon alfa-2b | PegIntron | Treatment of malignant melanoma stages IIb through IV.
PEG-interleukin-2 |  | Treatment of primary immunodeficiencies associated with T-cell defects.
Pegylated arginine deiminase | Melanocid | Treatment of invasive malignant melanoma.
Pegylated arginine deiminase | Hepacid | Treatment of hepatocellular carcinoma.
Pegylated recombinant human megakaryocyte growth and development factor | MEGAGEN | For reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation.
Peldesine |  | Treatment of cutaneous T-cell lymphoma.
Pentamidine isethionate |  | Treatment of Pneumocystis carinii pneumonia.
Pentamidine isethionate (inhalation) | Pneumopent | Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.
pentetate trisodium | diethylenetriaminepentaacetate | Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium.
[NAME] |  | Treatment of sickle cell disease.
[NAME] | Nipent | Treatment of patients with chronic lymphocytic leukemia.
[NAME] | Nipent | Treatment of peripheral T-cell lymphomas.
[NAME] | Nipent | Treatment of cutaneous T-cell lymphoma.
Peptide 144 TGF beta-1 inhibitor |  | Treatment of systemic sclerosis
Peptide 144 TGF beta-1-inhibitor |  | Treatment of localized scleroderma
Peptidomimetic analog of hexarelin |  | Diagnosis of growth hormone deficiency
Perflubron | LiquiVent | Treatment of acute respiratory distress disease (ARDS) in adults
Perfosfamide | Pergamid | For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
Pergolide | Permax | Treatment of Tourette's syndrome.
Phenylacetate |  | For use as an adjunct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.
Phenylalanine ammonia-lyase | Phenylase | Treatment of hyperphenylalaninemia.
Phenylbutyrate |  | Treatment of acute promyelocytic leukemia.
phenylephrine |  | Treatment of ileal pouch anal anastomosis related fecal incontinence
Phosphocysteamine |  | Treatment of cystinosis.
phosphorothioate antisense olignucleotide against EWS-Fli-1 |  | Treatment of Ewing's sarcoma
phosphorothioate oligonucleotide |  | Treatment of amyotrophic lateral sclerosis
Picoplatin |  | Treatment of small cell lung cancer
Piracetam | Nootropil | Treatment of myoclonus.
Piritrexim isethionate |  | Treatment of infections caused by Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium-intracellulare.
Plasmid DNA vector expressing cystic fibrosis transmembrane gene |  | Treatment of cystic fibrosis
plasmin (human) |  | Treatment of acute peripheral arterial occlusion (aPAO)
Plevitrexed | Plevitrexed | Treatment of ovarian cancer
Plevitrexed | Plevitrexed | Treatment of gastric (stomach) cancer
Plitidepsin | Aplidin | Treatment of acute lymphoblastic leukemia
Plitidepsin | Aplidin | Treatment of multiple myeloma
Poloxamer 188 |  | Treatment of vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm.
Poloxamer 188 | Flocor | Treatment of sickle cell crisis.
Poloxamer 188 | Florcor | Treatment of severe burns requiring hospitalization.
Poloxamer 331 | Protox | Initial therapy of toxoplasmosis in patients with AIDS.
Poly I: poly C12U | Ampligen | Treatment of renal cell carcinoma.
Poly I: poly C12U | Ampligen | Treatment of invasive metastatic melanoma (stage IIb, III, IV).
Poly I: poly C12U | Ampligen | Treatment of chronic fatigue syndrome.
Poly I: poly C12U | Ampligen | Treatment of AIDS.
Polyethylene glycol (PEG)-uricase |  | To control the clinical consequences of hyperuricemia in patients with severe gout in whom conventional therapy is contraindicated or has been ineffective.
Polyethylene glycol-modified uricase |  | Treatment of hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated
Polyethylene glycol-modified uricase | Zurase | Prophylaxis of hyperuricemia in cancer patients prone to develop tumor lysis syndrome during chemotherapy.
Polyethylene glycol-modified uricase | Zurase | Treatment of tumor lysis syndrome in cancer patients undergoing chemotherapy.
Poly-ICLC | Hiltonol | Treatment of primary brain tumors.
polyinosinic-polycytidilic acid | Poly-ICLC | Treatment of flavivirus infections including those due to West Nile, Japanese encephalitis, dengue, St. Louis encephalitis, yellow fever, [NAME] valley, and Banzai viruses
polyinosinic-polycytidilic acid | Poly-ICLC | As an adjuvant to smallpox vaccination
polyinosinic-polycytidilic acid (Poly-ICLC) | Hiltonol | Treatment for orthopox virus infections
[NAME] oxygen |  | Treatment of sickle cell anemia.
polyphenon E |  | Treatment of chronic lymphocytic leukemia
Polyvalent, shed-antigen melanoma vaccine |  | Treatment of stage IIb to stage IV melanoma
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation | NeuroCell-PD | Treatment of Hoehn and [NAME] stage 4 and 5 Parkinson's disease.
Porcine fetal neural dopaminergic cells and/or precursors aseptically prepared for intracerebral implantation. | NeuroCell-PD | Treatment of Hoehn and [NAME] stage 4 and 5 Parkinson's disease.
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared and coated with anti-MHC-1 Ab for intracerebral implantation | NeuroCell-HD | Treatment of Huntington's disease.
Porcine fetal neural gabaergic cells and/or precursors aseptically prepared for intracerebral implantation for Huntington's disease. | NeuroCell-HD | Treatment of Huntington's disease.
Porcine Sertoli cells aseptically prepared for intracerebral co-implantation with fetal neural tissue | N-Graft | Treatment of Hoehn and [NAME] stage four and five Parkinson's disease.
Porfimer sodium | Photofrin | Treatment of cholangiocarcinoma
Porfimer sodium | Photofrin | For the photodynamic therapy of patients with transitional cell carcinoma in situ of the urinary bladder.
Porfiromycin | Promycin | Treatment of cervical cancer.
Porfiromycin | Promycin | Treatment of head and neck cancer.
Posaconazole | Posoril | Treatment of zygomycosis
Potassium citrate and citric acid |  | For the dissolution and control of uric acid and cysteine calculi in the urinary tract.
potassium sodium aluminosilicate |  | For treatment of poisoning by or exposure to cesium.
PR1 Vaccine |  | Treatment of myelodysplastic syndromes requiring therapy
PR1 Vaccine |  | Treatment of acute myelogenous leukemia
PR1 Vaccine |  | Treatment of chronic myelogenous leukemia.
Pr-122 (redox-phenytoin) |  | For the emergency rescue treatment of status epilepticus, grand mal type.
PR-225 (redox-acyclovir) |  | Treatment of herpes simplex encephalitis in individuals afflicted with AIDS.
PR-239 ([NAME]) |  | Treatment of AIDS associated neurosyphilis.
Pr-320 (molecusol-carbamazepine) |  | For the emergency rescue treatment of status epilepticus, grand mal type.
pralatrexate |  | Treatment of diffuse large B-cell lymphoma
pralatrexate |  | Treatment of follicular lymphoma
pralatrexate |  | Treatment of T-cell lymphoma
pramipexole | Mirapex | Treatment of Tourette's syndrome in pediatric patients
[NAME] |  | For the management of cognitive dysfunction and enhancement of antidepressant activity associated with electroconvulsive therapy.
Praziquantel |  | Treatment of neurocysticercosis.
Prednimustine | Sterecyt | Treatment of malignant [NAME] lymphomas.
Primaquine phosphate |  | For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.
Procarbazine HCl | Matulane | Treatment of malignant glioma
Progesterone |  | Establishment and maintenance of pregnancy in women undergoing in vitro fertilization or embryo transfer procedures.
Propamidine isethionate 0.1% ophthalmic solution | [NAME] | Treatment of acanthamoeba keratitis.
propanolol |  | Treatment of proliferating infantile hemangiomas requiring systemic therapy
Prostaglandin E1 enol ester  (AS-013) | Circulase | Treatment of Fontaine Stage IV chronic critical limb ischemia.
[NAME] in lipid emulsion | Lipo-PGE1 | Treatment of ischemic ulceration of the lower limbs due to peripheral arterial disease.
Protaxel |  | Treatment of ovarian cancer
Protein C concentrate | Protein C Concentrate (human) [NAME], [NAME] | For use in the prevention and treatment of purpura fulminans in meningococcemia.
Protein C concentrate | Protein C Concentrate (human) [NAME], [NAME] | For replacement therapy in patients with congenital or acquired protein C deficiency for the prevention and treatment of warfarin-induced skin necrosis during oral anticoagulation.
[NAME] |  | Prevention of infant respiratory distress syndrome associated with prematurity.
[NAME] injection |  | Treatment of amyothrophic lateral sclerosis.
[NAME] surfactant replacement |  | Prevention and treatment of infant respiratory distress syndrome.
purified bovine type collagen |  | Treatment of idiopathic pulmonary fibrosis
Purified extract of Pseudomonas aeruginosa | ImmuDyn | Treatment of immune thrombocytopenia purpura where it is required to increase platelet counts.
Purified type II collagen | Colloral | Treatment of juvenile rheumatoid arthritis.
Pyruvate |  | Treatment of interstitial lung disease.
Quinacrine hydrochloride |  | For prevention of recurrence of pneumothorax in patients at high risk of recurrence.
quinine sulfate |  | Treatment of malaria excluding Plasmodium faliparum
R-(-)-gossypol |  | Treatment of chronic lymphocytic leukemia.
R-4-amino-3-(4-chlorophenyl)butanoic acid |  | Treatment of the behavorial abnormalities associated with fragile X syndrome.
rAAV2-CB-hRPE65 |  | Treatment of type II Leber's Congential Amaurosis
Rabbit anti-human thymocyte globulin (rATG) | Thymoglobulin | Induction treatment to prevent rejection and to minimize maintenance immunosupression in pediatric liver transplant recipients
ranprinase | Onconase | Treatment of malignant mesothelioma
Rapamycin |  | Treatment of tuberous sclerosis complex
Rapamycin (mTOR) inhibitor |  | Treatment of bone sarcoma
[NAME] | Abthrax | Treatment of anthrax
recombinant adeno-associated virus alpha 1-antitrypsin vector | rAAV-AAT | Treatment of alpha1-antitrypsin deficiency
Recombinant anti-CD22 immunotoxin |  | Treatment of CD22-positive chronic lymphocytic leukemia
Recombinant anti-CD22 immunotoxin |  | Treatment of hairy cell leukemia
Recombinant anti-CD40 monoclonal antibody |  | Treatment of chronic lymphocytic leukemia
Recombinant anti-CD-40 monoclonal antibody |  | Treatment of multiple myeloma
Recombinant bactericidal/permeability-increasing protein | Neuprex | Treatment of severe meningococcal disease.
recombinant chimeric monoclonal antibody to anthrax | Anthim | Treatment of exposure to [NAME] spores
Recombinant coagulation factor VIIa | Novoseven | Treatment of diffuse alveolar hemorrhage
Recombinant deriative of C3 transferase | Cethrin | Treatment of acute spinal cord injury
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs |  | Treatment of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms.
Recombinant disintegrin and metalloprotease with thrombospondin type 1 motifs |  | Prevention of thrombotic thrombocytopenic purpura including its congential, acquired idiopathic and secondary forms.
Recombinant [NAME] virus gp350 glycoprotein vaccine |  | Prevention of post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation
Recombinant fully human monoclonal antibody to anthrax protective antigen | Valortim | Treatment of anthrax infection
recombinant fusion protein with a truncated form of the cytotoxic protein Pseudomonas exotoxin | Proxinium | Treatment of Ep-CAM-positive squamous cell carcinoma of the head and neck
Recombinant glycine2-human glucagon-like peptide-2 |  | Treatment of short bowel syndrome.
Recombinant human alpha 1-antitrypsin |  | Prevention of bronchopulmonary dysplasia
recombinant human alpha 1-antitrypsin (rAAT) |  | Treatment of cystic fibrosis
recombinant human alpha-1 antitrypsin |  | Treatment of cystic fibrosis.
recombinant human alpha-1 antitrypsin (rAAT) |  | To delay progression of chronic obstructive pulmonary disease resulting from AAT deficiency-mediated emphysema and bronchiectasis
Recombinant Human Alpha-Fetoprotein (rhAFP) |  | Treatment of myasthenia gravis
Recombinant human alpha-mannosidase |  | Treatment of alpha-mannosidosis
Recombinant human anti-GDF-8 (growth and differentiation factor-8) antibody |  | Treatment of [NAME] and Becker muscular dystrophies
Recombinant human antithrombin III |  | Treatment of antithrombin III dependent heparin resistance requiring anticoagulation.
recombinant human arylsulphatase A |  | Treatment of metachromatic leukodystrophy (MLD).
Recombinant human C1 inhibitor |  | Treatment of capillary leakage syndrome
Recombinant human C1 inhibitor |  | Prevention and/or treatment of delayed graft function after solid organ transplantation
Recombinant human C1-esterase inhibitor |  | Treatment of (acute attacks of) angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.
Recombinant human C1-esterase inhibitor |  | Prophylactic treatment of angioedema caused by hereditary or acquired C1-esterase inhibitor deficiency.
Recombinant human CD4 immunoglobulin G |  | Treatment of AIDS resulting from infection with HIV-1.
Recombinant human [NAME] 10kDa protein |  | Prevention of neonatal bronchopulmonary dysplasia in premature neonates with respiratory distress syndrome.
recombinant human coagulation factor IX fusion protein |  | For the control and prevention of hemorrhagic episodes in patients with hemophilia B (congential factor IX deficiency or Christmas disease).
Recombinant human endostatin protein |  | Treatment of neuroendocrine tumors
recombinant human endostatin protein |  | Treatment of metastatic melanoma
Recombinant human fibrinogen |  | Treatment of bleeding in patients deficient in fibrinogen
recombinant human fibroblast growth factor-20 |  | Treatment of radiation induced oral mucositis
Recombinant human gelsolin |  | Treatment of acute and chronic respiratory symptoms of bronchiectasis.
Recombinant human gelsolin |  | Treatment of the respiratory symptoms of cystic fibrosis.
Recombinant human granulocyte colony stimulating factor |  | Prevention of implantation failure
Recombinant human highly phosphorylated acid alpha-glucosidase | TBD | For enzyme replacement therapy in patients with all subtypes of glycogen storage disease type II (GSDII, Pompe Disease)
recombinant human histone H1.3; recombinant human N-bis-met-histone H1.3 | Oncohist (r) | Treatment of acute myeloid leukemia
Recombinant human insulin-like growth factor 1 | IGF-1 | Treatment of growth hormone receptor deficiency.
Recombinant human insulin-like growth factor 1 | IGF-1 | Treatment of antibody-mediated growth hormone resistance in patients with isolated growth hormone deficiency Ia.
Recombinant human insulin-like growth factor-I | PV802 | Treatment of short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines.
Recombinant human insulin-like growth factor-I |  | Treatment of post-poliomyelitis syndrome.
Recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein-3 |  | Treatment of major burns that require hospitalization.
Recombinant human interleukin-12 |  | Treatment of renal cell carcinoma.
Recombinant Human Interleukin-21 (rIL-21) |  | Treatment of stage II (T4), III or IV malignant melanoma.
Recombinant human keratinocyte growth factor |  | Reducing the incidence and severity of radiation-induced xerostomia.
Recombinant human lysosomal acid lipase or [NAME] hydrolase | Cholestrase | Treatment of lipase deficiencies, including Wolman Disease and [NAME] storage disease
Recombinant human microplasmin |  | Treatment of peripheral arterial occlusion
recombinant human minibody against complement component C5 | MUBODINA | Treatment of primary membranoproliferative glomerulonephritis
recombinant human minibody against complement component [NAME] fused with RGD-motif |  | Prevention of ischemmia/reperfusion injury associated with solid organ transplantation.
recombinant human monoclonal antibody to hsp90 | Mycograb | Treatment of invasive candidiasis
Recombinant human nerve growth factor |  | Treatment of HIV-associated sensory neuropathy.
recombinant human neutrophil inhibitor (hNE) |  | Treatment of cystic fibrosis
Recombinant human platelet derived growth factor BB |  | Treatment of osteonecrosis of the jaws
recombinant human porphobilinogen deaminase | Porphozyme | Treatment of acute intermittent porphyria attacks
recombinant human porphobilinogen deaminase, erythropoetic form |  | Treatment of acute intermittent porphyria preventing attacks
recombinant human proinsulin |  | Treatment of retinitis pigmentosa
Recombinant human relaxin |  | Treatment of progressive systemic sclerosis.
recombinant human rod-derived cone viability factor |  | Treatment of retinitis pigmentosa
Recombinant human thrombopoietin |  | For use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation.
recombinant human type I pancreatic elastase |  | Prevention of arteriovenous fistula maturation and arteriovenous graft failure in patients with end stage renal disease who are receiving hemodialysis or preparing for hemodialysis
recombinant human type VII collagen |  | Treatment of hereditary dystrophic epidermolysis bullosa (DEB)
Recombinant humanized [NAME] |  | Prevention of rejection of solid organ transplants.
Recombinant humanized [NAME] |  | Prevention of rejection of pancreatic islet cell transplants.
Recombinant humanized [NAME] |  | Prevention and treatment of Factor VIII/Factor IX inhibitors in patients with hemophilia A or B.
Recombinant humanized monclonal antibody 5c8 |  | Treatment of immune thrombocytopenic purpura.
Recombinant humanized monoclonal antibody 5c8 |  | Treatment of systemic lupus erythematosus.
Recombinant methionyl brain-derived neurotrophic factor |  | Treatment of amyotrophic lateral sclerosis.
recombinant ovine interferon tau | Tauferon | Treatment of pediatric multiple sclerosis
Recombinant Porcine Factor VIII, B-domain Deleted |  | Treatment and prevention of episodic bleeding in patients with inhibitor antibodies to human coagulation factor VIII
Recombinant P-Selectin glycoprotein ligand |  | Prevention of delayed graft function in renal transplant patients
Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig |  | Prevention of ischemia reperfusion injury in all solid organ transplants
Recombinant retroviral vector - glucocerebrosidase |  | For use as enzyme replacement therapy for patients with types I, II, or III Gaucher disease.
Recombinant secretory leucocyte protease inhibitor |  | Treatment of cystic fibrosis.
Recombinant secretory leucocyte protease inhibitor |  | Treatment of congenital alpha-1 antitrypsin deficiency.
Recombinant soluble human CD4 | Receptin | Treatment of acquired immunodeficiency syndrome.
Recombinant soluble human CD4 (rCD4) |  | Treatment of AIDS in patients infected with HIV virus.
Recombinant T-cell receptor ligand |  | Treatment of multiple sclerosis patients who are both HLA-DR2 positive and autoreactive to [NAME] glycoprotein residues 35-55
Recombinant truncated SPINT2 protease inhibitor |  | Treatment of cystic fibrosis
Recombinant urate oxidase |  | Prophylaxis of chemotherapy-induced hyperuricemia.
Reduced L-glutathione | Cachexon | Treatment of AIDS-associated cachexia.
Remacemide | Ecovia | Treatment of Huntington's disease.
Reparixin |  | Prevention of delayed graft function in solid organ transplant
repository corticotropin or adrenocorticotropic hormone | [NAME] | Treatment of infantile spasms
resiniferatoxin |  | Treatment of intractable pain at end-stage disease
reslizumab |  | Treatment of children with eosinophilic esophagitis
Respiratory Syncytial Virus Immune Globulin (human) | [NAME] | Treatment of respiratory syncytial virus lower respiratory tract infections in hospitalized infants and young children.
retaspimycin |  | Treatment for gastrointestinal stromal tumor
retaspimycin hydrochloride |  | Treatment of melanoma stages IIb through IV.
R-etodolac |  | Treatment of chronic lymphocytic leukemia
retroviral gamma-c cDNA containing vector |  | Treatment of X linked severe combined immune deficiency disease
Retroviral vector, R-GC and GC gene 1750 |  | Treatment of Gaucher disease.
Reviparin sodium | Clivarine | Treatment of deep vein thrombosis which may lead to pulmonary embolism in pediatric patients
Reviparin sodium | Clivarine | Long-term treatment of acute deep vein trombosis with or without pulmonary embolism in pregnant patients
RGG0853, E1A lipid complex |  | Treatment of ovarian cancer.
rhIGF-I/rhIGFBP-3 | SomatoKine | Treatment of extreme insulin resistance syndromes (type A, Rabson-Mendenhall syndrome, Leprechaunism, Type B syndrome)
rh-microplasmin |  | Adjunct to surgery in cases of pediatric vitrectomy
Ribavirin | Virazole | Treatment of hemorrhagic fever with renal syndrome.
Ricin (blocked) conjugated murine mca (anti-b4) |  | For the ex-vivo purging of leukemic cells from the bone marrow of non-T cell acute lymphocytic leukemia patients who are in complete remission.
Ricin (blocked) conjugated murine MCA (anti-B4) |  | Treatment of B-cell leukemia and B-cell lymphoma.
Ricin (blocked) conjugated murine MCA (anti-my9) |  | Treatment of myeloid leukemia, including AML, and blast crisis of CML.
Ricin (blocked) conjugated murine MCA (anti-my9) |  | For use in the ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia.
Ricin (blocked) conjugated murine MCA (n901) |  | Treatment of small cell lung cancer
Ricin (blocked) conjugated murine monoclonal antibody (CD6) |  | Treatment of cutaneous T-cell lymphomas, acute T-cell leukemia-lymphoma, and related mature T-cell malignancies.
Rifabutin |  | Treatment of disseminated Mycobacterium avium complex disease.
Rifalazil |  | Treatment of pulmonary tuberculosis.
Rifapentine | Priftin | Prophylactic treatment of Mycobacterium avium complex in patients with AIDS and a CD4+ count less than or equal to 75/mm3.
Rifapentine | Priftin | Treatment of Mycobacterium avium complex in patients with AIDS.
Rifaximin | Normix | Treatment of hepatic encephalopathy
RII retinamide |  | Treatment of myelodysplastic syndromes.
Riluzole | Rilutek | Treatment of Huntington's disease.
risedronate sodium | Actonel | Treatment of patients with osteogenesis imperfecta.
rituximab | Rituxan | Treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (Wegener's Granulomatosis, [NAME], and Churg-Strauss Syndrome)
rituximab | Rituxan | Treatment of immune thrombocytopenic purpura
rituximab | Rituxan | Treatment of chronic lymphocytic leukemia
RNA, ((2',3'-dideoxy-2',3'-imino-2',3'-seco)[dimethylamino)phosphinylideneoxy](2'a-5') (CTC CAA CAT CAA GGA AGATGG CAT TTC TAG)), P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylaminophosphonamidate |  | Treatment of Duchenne Muscular Dystrophy.
rofecoxib | [NAME] | Treatment of juvenile rheumatoid arthritis
[NAME] |  | Treatment of non-Hodgkin T-cell lymphomas
Roquinimex | Linomide | To prolong time to relapse in leukemia patients who have undergone autologous bone marrow transplantation.
Rose Bengal Disodium |  | Treatment of metastatic melanoma
rSP-C lung surfactant | Venticute | Treatment of adult respiratory distress syndrome.
rSP-C surfactant | Venticute | For use in patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygen impairment
rubitecan |  | Treatment of pediatric patients infected with human immunodeficiency virus and acquired immunodeficiency syndrome
S(-)-3-[3-amino-phthalimido]-glutaramide |  | Treatment of multiple myeloma
S-adenosylmethionine |  | Treatment of AIDS-myelopathy.
salirasib |  | Treatment of panreatic cancer.
sarsasapogenin |  | Treatment of amyotrophic lateral sclerosis (ALS)
SB-408075 |  | For pancreatic cancer
SC-1 monoclonal antibody |  | Treatment of patients with CD55 (sc-1) positive gastric tumors
SCH 58500 |  | Treatment of primary ovarian cancer.
SDF-1 (108) [NAME] |  | Treatment of osteogenic sarcoma
Secalciferol | Osteo-D | Treatment of familial hypophosphatemic rickets.
Secretory leukocyte protease inhibitor |  | Treatment of bronchopulmonary dysplasia.
Seneca Valley virus |  | Treatment of neuroendocrine tumors
Sermorelin acetate | Geref | Adjunct to gonadotropin therapy in the induction of ovulation in women with anovulatory or oligo-ovulatory infertility who fail to ovulate in response to adequate treatment with clomiphene citrate alone and gonadotropin therapy alone.
Sermorelin acetate | Geref | Treatment of AIDS-associated catabolism/weight loss.
Serratia marcescens extract (polyribosomes) | Imuvert | Treatment of primary brain malignancies.
SGN-30 (anti-CD30 antibody) |  | Treatment of CD30 positive T-cell lymphomas
SGN-30 (anti-CD30 mAb) |  | Treatment of Hodgkin's disease
SGN-35 (cAC10-vcMMAE(4)) |  | Treatment of anaplastic large cell lymphoma
SGN-40 (anti-CD40 antibody) |  | Treatment of multiple myeloma.
Short chain fatty acid enema | Colomed | Treatment of chronic radiation proctitis.
Short chain fatty acid solution | Colomed | Treatment of the active phase of ulcerative colitis with involvement restricted to the left side of the colon.
Silver sulfadiazine and cerium nitrate | Flammacerium | Prevention of mortality in severely burned patients.
siplizumab |  | Treatment of T-cell lymphomas
Sitaxsentan Sodium |  | For the treatment of pulmonary arterial hypertension in the absence of chronic obstructive pulmonary disease or congestive heart failure.
SK&F 110679 |  | For the long term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
sodium 2, 2 dimethylbutyrate |  | Treatment of sickle cell disease.
sodium 4-{ [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-d] [2] benzazepin-2-yl]-2-methoxybenzoate |  | Treatment of ovarian cancer
Sodium aluminosilicate |  | Treatment of chronic hepatic encephalopathy
Sodium ascorbate and menadione sodium bisulfite | Apatone | Treatment of metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium (stage III and IV bladder cancer)
Sodium dichloroacetate |  | Treatment of homozygous familial hypercholesterolemia.
Sodium dichloroacetate |  | Treatment of congenital lactic acidosis.
Sodium dichloroacetate |  | Treatment of congenital lactic acidosis.
Sodium dichloroacetate |  | Treatment of lactic acidosis in patients with severe malaria.
sodium dichloroacetate |  | Use as an antidote in the management  of systemic monochloroacetic acid  poisoning
Sodium dichloroacetate | Ceresine | Treatment of severe head injury.
[NAME]-closo-dodecaborate | [NAME] | For use in boron neutron capture therapy (BNCT) in the treatment of glioblastoma multiforme.
Sodium monomercaptoundecahydro-closo-dodecaborate |  | For use in conjunction with a thermal or epithermal neutron beam in boron nuclear capture therapy of glioblastoma multiforme.
Sodium nitrite |  | Treatment of vaso-occlusive crisis associated with sickle cell disease
Sodium nitrite |  | Treatment of cyanide poisoning
Sodium nitrite |  | Prevention of vasospasm associated with subarachnoid hemorrhage
sodium nitrite |  | Treatment of pulmonary arterial hypertension
Sodium nitrite and sodium thiosulfate | Cyanide [NAME] | Treatment of known or suspected cyanide poisoning
Sodium nitrite/sodium thiosulfate | Cyanide Antidote Package | Treatment of cyanide poisoning
Sodium phenylacetate/sodium benzoate 10%/10% Injection | Ammonul | Treatment of grade III and IV hepatic encephalopathy
Sodium phenylbutyrate |  | Treatment of spinal muscular atrophy
Sodium phenylbutyrate | Buphenyl | Treatment of spinal muscular atrophy
Sodium phenylbutyrate |  | For use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma.
sodium phenylbutyrate |  | Treatment for sickling disorders, which include S-S hemoglobinopathy, S-C hemoglobinopathy, and S-thalassemia hemoglobinopathy.
Sodium pyruvate |  | Treatment of cystic fibrosis
Sodium stibogluconate |  | Treatment of cutaneous leishmaniasis
Sodium thiosulfate |  | Prevention of platinum-induced ototoxicity in pediatric patients
Sodium thiosulfate and sodium nitrite |  | Treatment of cyanide poisoning
Sodium thiosulfate, sodium nitrite, amyl nitrite | Cyanide Antidote Package | Treatment of cyanide poisoning
Solasonine and solamargine | Coramsine | Treatment of renal cell carcinoma
Solasonine and solamargine | Coramsine | Treaatment of high risk stage II, stage III and stage IV melanoma
Soluble complement receptor type 1 |  | Prevention of post-cardiopulmonary bypass syndrome in children undergoing cardiopulmonary bypass.
Soluble recombinant human complement receptor type 1 |  | Prevention or reduction of adult respiratory distress syndrome.
Solvent/detergent treated non-blood group specific human coagulation active plasma | UNIPLAS | Treatment of thrombotic thrombocytopenic purpura
[NAME] | Zecnil | Adjunct to the non-operative management of secreting cutaneous fistulas of the stomach, duodenum, small intestine ([NAME] and ileum), or pancreas.
[NAME] |  | Treatment of bleeding esophageal varices.
[NAME] for injection | Protropin | Treatment of short stature associated with Turner's syndrome.
Somatropin | Humatrope | Treatment of short stature in pediatric patients with short stature homeobox-containing gene (SHOX) deficiency
Somatropin | Norditropin | Treatment of short stature associated with Turner's syndrome.
Somatropin | Norditropin | Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.
Somatropin | Biotropin | Treatment of cachexia associated with AIDS.
Somatropin | Serostim | Treatment of patients with HIV-associated adipose redistribution syndrome
Somatropin  (rDNA) | [NAME] | For the enhancement of nitrogen retention in hospitalized patients suffering from severe burns.
Somatropin (r-DNA) for injection | Serostim | Treatment of children with AIDS-associated failure-to-thrive including AIDS-associated wasting.
Sorafenib | Nexavar | Treatment of stage IIB through stage IV melanoma
Sorivudine | BRAVAVIR | Treatment of herpes zoster (shingles) in immunocompromised patients.
Sotalol HCl | Betapace | Prevention of life threatening ventricular tachyarrhythmias.
spherical carbon adsorbent |  | Treatment of chronic pouchitis
Spiramycin | Rovamycine | For symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency.
squalamine lactate |  | Treatment of ovarian cancer refractory or resistant to standard chemotherapy
SS1(dsFv)-PE38 |  | Treatment of epithelial ovarian cancer
SS1(dsFv)-PE38 |  | Treatment of malignant mesothelioma
ST1-RTA immunotoxin (SR 44163) |  | Treatment of patients with B-chronic lymphocytic leukemia.
ST1-RTA immunotoxin (SR 44163) |  | Prevention of acute graft versus host disease in allogenic bone marrow transplantation.
Staphylococcus aureus Immune Globulin (Human) | Altastaph | Prophylaxis against Staphylococcus aureus infections in low birth weight neonates
Stem and progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood | StemEx | For use as hematopoietic support in patients with relasped or refractory hematologic malignancies who are receiving high-dose therapy
Sterile talc | Steritalc | Treatment of malignant pleural effusion.
Sterile talc | Steritalc | Treatment of pneumothorax.
stiripentol | [NAME]) | Treatment of Dravet syndrome
SU101 |  | Treatment of ovarian cancer.
SU101 |  | Treatment of malignant glioma.
Succimer | Chemet | Treatment of mercury intoxication.
Succimer | Chemet | Prevention of cystine kidney stone formation in patients with homozygous cystinuria who are prone to stone development.
Sucralfate |  | Treatment of oral mucositis and stomatitis following radiation therapy for head and neck cancer.
Sucralfate suspension |  | Treatment of oral complications of chemotherapy in bone marrow transplant patients.
Sucralfate suspension |  | Treatment of oral ulcerations and dysphagia in patients with epidermolysis bullosa.
sulfamidase |  | For treatment of Sanfilippo Syndrome.
Sulfapyridine |  | Treatment of dermatitis herpetiformis.
Superoxide dismutase (human) |  | For protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure.
Superoxide dismutase (recombinant human) | Oxsodrol | Prevention of reperfusion injury to donor organ tissue.
Suramin | Metaret | Treatment of hormone-refractory prostate cancer.
Surfactant (human) (amniotic fluid derived) | Human Surf | Prevention and treatment of neonatal respiratory distress syndrome.
Synsorb Pk |  | Treatment of verocytotoxogenic E. coli infections.
Synthetic Human Parathyroid Hormone 1-34 |  | Treatment of hypoparathyroidism
Synthetic human secretin |  | For use in conjunction with diagnostic procedures (excluding ERCP) for pancreatic disorders to increase pancreatic fluid secretion
Synthetic human secretin |  | For use in the diagnosis of gastrinoma associated with [NAME] syndrome.
Synthetic human secretin |  | For use in conjunction with diagnostic procedures for pancreatic disorders to increase pancreatic fluid secretion.
Synthetic human secretin |  | For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.
Synthetic human secretin |  | For use in the evaluation of exocrine pancreas function.
Synthetic porcine secretin |  | For use in obtaining desquamated pancreatic cells for cytopathologic examination in pancreatic carcinoma.
T4 endonuclease V, liposome encapsulated |  | To prevent cutaneous neoplasms and other skin abnormalities in xeroderma pigmentosum.
Tacrolimus | Prograf | Prophylaxis of graft-versus-host-disease.
Tadalafil | [NAME] | Treatment of pulmonary arterial hypertension
TAK-603 |  | Treatment of Crohn's disease.
Talactoferrin alfa |  | Treatment of non-small cell lung cancer
[NAME] |  | Treatment of renal cell carcinoma
[NAME] |  | For the treatment of graft versus host disease
[NAME] |  | For the prevention of graft-versus-host disease
talampanel |  | Treatment of glioma
talampanel |  | Treatment of amyotrophic lateral sclerosis
Tamibarotene |  | Treatment of acute promyelocytic leukemia (APL).
Tanespimycin |  | Treatment of multiple myeloma
T-cell depleted stem cell enriched cellular product from peripheal b lood stem cells |  | Treatment of chronic granulomatous disease
TD-K6a.513a.12 | ReveKer | Treatment of pachyonychia congenita
Technetium Tc 99m pterotetramide |  | For the identification of ovarian carcinomas.
Technetium Tc99m anti-melanoma murine monoclonal antibody | Oncotrac Melanoma Imaging Kit | For use in detecting, by imaging, metastases of malignant melanoma.
Technetium Tc99m murine monoclonal antibody (IgG2a) to B cell | LymphoScan | Diagnostic imaging in the evaluation of the extent of disease in patients with histologically confirmed diagnosis of non-Hodgkin's B-cell lymphoma, acute B-cell lymphoblastic leukemia (in children and adults), and chronic B-cell lymphocytic leukemia.
Technetium Tc99m murine monoclonal antibody to hCG | Immuraid, hCG-Tc-99m | Detection of hCG producing tumors such as germ cell and trophoblastic cell tumors.
Technetium Tc99m murine monoclonal antibody to human AFP | AFP-Scan | Detection of alpha-fetoprotein producing germ cell tumors.
Technetium Tc99m murine monoclonal antibody to human alpha-fetoprotein | Immuraid, AFP-Scan | Detection of hepatocellular carcinoma and hepatoblastoma.
Technetium Tc99m rh-Annexin V | Apomate | Diagnosis or assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants.
Tegafur/gimeracil/oteracil |  | Treatment of gastric cancer
temocillin sodium | Negaban | Treatment of pulmonary infections caused by Burkholderia cepacia
Temoporfin | Foscan | Palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy.
Temozolomide | Temodal | Treatment of newly diagnosed high grade glioma
Temozolomide | Temodal | Treatment of advanced metastatic melanoma.
tenofovir disoproxil fumarate | Viread(r) | Treatment of pediatric HIV infection.
terguride |  | Treatment of pulmonary arterial hypertension
Teriparatide | [NAME] | Treatment of idiopathic osteoporosis.
Terlipressin | [NAME] | Treatment of bleeding esophageal varices.
Terlipressin (INN) |  | Treatment of Hepatorenal Syndrome
tesetaxel |  | Treatment of  stages IIB, IIC, III, and stage IV melanoma
tesetaxel |  | Treatment of gastric cancer
Testosterone | TheraDerm Testosterone Transdermal System | For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss.
Testosterone propionate ointment 2% |  | Treatment of vulvar dystrophies.
Testosterone sublingual |  | Treatment of constitutional delay of growth and puberty in boys.
Tetrabenazine |  | Treatment of moderate/severe tardive dyskinesia.
Tetraiodothyroacetic acid |  | Suppression of thyroid stimulating hormone in patients with well-differentiated cancer of the thyroid gland.
Tezacitabine |  | Treatment of adenocarcinoma of the esophagus and stomach
TGF(beta)2-specific phosphorothioate antisense oligodeoxynucleotide | Oncomun | Treatment of malignant glioma
TGp1PTH1-34 |  | Treatment of solitary (unicameral) bone cysts.
Thalidomide | Thalomid | Treatment of myelodysplastic syndrome
Thalidomide |  | Treatment and prevention of recurrent aphthous ulcers in severely, terminally immunocompromised patients.
Thalidomide | Synovir | Treatment of HIV-associated wasting syndrome.
Thalidomide | Thalomid | Treatment of Crohn's disease.
Thalidomide |  | Prevention of graft versus host disease in patients receiving bone marrow transplantation.
Thalidomide |  | Treatment of graft versus host disease in patients receiving bone marrow transplantation.
Thalidomide |  | Treatment and maintenance of reactional lepromatous leprosy.
Thalidomide |  | Treatment of the clinical manifestations of mycobacterial infection caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Thalidomide |  | Prevention of graft versus host disease.
Thalidomide |  | Treatment of graft versus host disease.
Thalidomide |  | Treatment of primary brain malignancies.
Thalidomide |  | Treatment of severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients.
Thalidomide |  | Treatment of Kaposi's sarcoma.
Thiotepa | Tepadina | Conditioning treatment prior to hematopoietic stem cell transplantation
Thymalfasin | [NAME] | Treatment of stage IIb through Stage IV malignant melanoma
Thymalfasin | [NAME] | Treatment of chronic active hepatitis B.
Thymalfasin | [NAME] | Treatment of DiGeorge anomaly with immune defects.
Thymalfasin | [NAME] | Treatment of hepatocellular carcinoma.
Thymosin beta 4 |  | Treatment of epidermolysis bullosa
Thymoxamine HCl |  | Reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma following mydriasis.
Tiapride |  | Treatment of Tourette's syndrome.
Tiazofurin (2-Beta-D-ribofuranosyl-4-thiazolecarboxamide) |  | Chronic myelogenous leukemia (CML)
Tilarginine acetate |  | Treatment of cardiogenic shock
tin ethyl etiopurpurin |  | Prevention of access graft disease in hemodialysis patients
Tiotropium bromide | Spiriva | To improve pulmonary function in conjunction with standard therapy in the management of patients with cystic fibrosis
Tipifarnib | Zarnestra | Treatment of acute myeloid leukemia
tirapazamine |  | Treatment of head and neck cancer
Tiratricol | Triacana | For use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone.
Tissue repair cells obtained from autologous bone marrow expanded ex vivo with a cell production system |  | Treatment of osteonecrosis
Tissue repair cells obtained from autologous bone marrow expanded ex vivo with a cell production system |  | Treatment of dilated cardiomyopathy
Titanium dioxide and bisoctrizole |  | For the secondary prevention (prevention of lesional induction) of disorders with UV-A and visible light-induced photosensitivity, specifically Actinic prurigo, Hydroa vacciniforme, Solar urticara (SU), Chronic Actinic Dermatitis (CAD), the cutaneous prop
Tizanidine HCl | Zanaflex | Treatment of spasticity associated with multiple sclerosis and spinal cord injury.
Tobramycin | Tobi | Treatment of bronchiectasis patients infected with Pseudomonas aeruginosa.
[NAME] for inhalation | Fluidosomes | Treatment of chronic pulmonary infection due to P. aeruginosa in cystic fibrosis patients
Tocophersolan oral  solution (vitamin E-tpgs) |  | Treatment of vitamin E deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease.
toralizumab |  | Treatment of immune thrombocytopenic purpura
[NAME] |  | Treatment of desmoid tumors.
Tosedostat |  | Treatment of acute myeloid leukemia
trabectedin | [NAME] | Treatment of soft tissue sarcoma.
trabectedin | [NAME] | Treatment of patients with ovarian cancer
Tramadol hydrochloride |  | Management of postherpetic neuralgia
Tramadol hydrochloride |  | Treatment of painful HIV-associated neuropathy
Tranexamic acid | Cyklokapron | Treatment of patients undergoing prostatectomy where there is hemorrhage or risk of hemorrhage as a result of increased fibrinolysis or fibrinogenolysis.
Tranexamic acid | Cyklokapron | Treatment of hereditary angioneurotic edema.
Tranilast | Rizaben | For the treatment of maligant glioma
Transforming growth factor-beta 2 |  | Treatment of full thickness macular holes.
Transgenic human alpha 1 antitrypsin |  | Treatment of emphysema secondary to alpha 1 antitrypsin deficiency.
[NAME] | [NAME] | Treatment of patients with pancreatic cancer that overexpress p185HER2.
[NAME] | Ovastat | Treatment of ovarian cancer.
Tretinoin | ATRA-IV | Treatment of acute and chronic leukemia.
Tretinoin | ATRA-IV | Treatment of T-cell  [NAME] lymphoma
Tretinoin |  | Treatment of squamous metaplasia of the ocular surface epithelia (conjunctiva and/or cornea) with mucous deficiency and keratinization.
tri-antennary glycotripeptide derivative of 5-fluorodeoxyuridine monophosphate |  | Treatment for hepatocellular carcinoma
triciribine |  | Treatment of multiple myeloma
Triheptanoin | Triheptanoin-SASOL Special Oil | Treatment of glycogen storage disorder II (Pompe disease)
Triheptanoin | Triheptanoim-SASOl Special Oil | Treatment of fatty acid disorders
Trimetrexate | [NAME] | Treatment of metastatic osteogenic sarcoma.
Trimetrexate glucuronate |  | Treatment of patients with advanced non-small cell carcinoma of the lung.
Trimetrexate glucuronate |  | Treatment of pancreatic adenocarcinoma.
Trimetrexate glucuronate |  | Treatment of metastatic colorectal adenocarcinoma.
Trimetrexate glucuronate |  | Treatment of metastatic carcinoma of the head and neck (i.e. buccal cavity, pharynx, and [NAME]).
Triptorelin pamoate | Decapeptyl Injection | For use in the palliative treatment of advanced ovarian carcinoma of epithelial origin.
Trisaccharides A and B | Biosynject | Treatment of moderate to severe clinical forms of hemolytic disease of the newborn arising from placental transfer of antibodies against blood group substances A and B.
Trisaccharides A and B | Biosynject | Prevention of ABO medical hemolytic reactions arising from ABO-incompatible bone marrow transplantation.
Trisaccharides A and B |  | Treatment of moderate to very severe clinical forms of transfusion reactions arising from ABO incompatible transfusions of blood, blood products, and blood derivatives.
Trisaccharides A and B | Biosynject | For use in ABO-incompatible solid organ transplantation, including kidney, heart, liver and pancreas.
Trisodium citrate concentration | Hemocitrate | For use in leukapheresis procedures.
Trisodium zinc Diethylenetriaminepentaacetate |  | Treatment of patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rate of elimination.
Troxacitabine | Troxatyl | Treatment of acute myeloid leukemia
Tumor necrosis factor-binding protein 1 |  | Treatment of symptomatic patients with AIDS including all patients with CD4 counts less than 200 cells per mm3.
Tumor necrosis factor-binding protein II |  | Treatment of symptomatic patients with the AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.
Tyloxapol | Supervent | Treatment of cystic fibrosis.
Type 1 native bovine skin collagen |  | Treatment of diffuse systemic sclerosis
[NAME] inhibitor |  | Treatment of mastocytosis
Ubiquinol | Ubi-Q-Nol, [NAME] | Treatment of Huntington's Disease
Ubiquinol, coenzyme Q10, ubiquinone | UBI-Q-NOL | Treatment of pediatric congestive heart failure
Ubiquinone | Ubi-Q-Gel | Treatment of mitochondrial cytopathies.
Unconjugated Chimeric (human-murine) G250 IgG monoclonal antibody |  | Treatment of renal cell carcinoma.
Urea for intravitreal injection | Neurosolve | Treatment of retinitis pigmentosa
Uridine 5'-triphosphate |  | To facilitate the removal of lung secretions in the treatment of patients with primary [NAME].
Uridine 5'-triphosphate |  | Treatment of cystic fibrosis.
Urofollitropin | Fertinex | For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism.
Urogastrone |  | For acceleration of corneal epithelial regeneration and healing of stromal incisions from corneal transplant surgery.
ursodiol | [NAME] | Treatment of cystic fibrosis liver disease
Ursodiol | Actigall | Management of the clinical signs and symptoms associated with primary biliary cirrhosis.
Valine, isoleucine and leucine | VIL | Treatment of hyperphenylalaninemia
[NAME] |  | Treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HSV1 and HSV2.
Valproate |  | Treatment of fragile X syndrome
Valproic acid, sodium | PEAC | Treatment of familial adenomatous polyposis
Vandetanib | Zactima | Treatment of patients with follicular thyroid carcinoma, medullary thyroid carcinoma, anaplastic thyroid carcinoma, and locally advanced and metastatic papillary thyroid carcinoma
Vapreotide | Sanvar | Treatment of symptomatic carcinoid tumors
vapreotide | Sanvar | Treatment of esophageal variceal hemorrhage patients with portal hypertension.
vapreotide | [NAME] | Treatment of gastrointestinal and pancreatic fistulas.
vapreotide | [NAME] | Prevention of early postoperative complications following pancreatic resection.
vapreotide | Sanvar | Treatment of acromegaly
varespladib sodium |  | Prevention of acute chest syndrome in at-risk patients with sickle cell disease
Varicella [NAME] (Human) | VariZIG | Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella
vascular endothelial growth factor 165b |  | Treatment of advanced melanoma stages IIb through IV.
Vasoactive intestinal peptide |  | Treatment of Acute Respiratory Distress Syndrome.
Vasoactive intestinal polypeptide |  | Treatment of acute esophageal food impaction.
veltuzumab |  | Treatment of chronic lymphocytic leukemia
[NAME] | Vibrilase | Debridement of severe, deep dermal burns in hospitalized patients
vigabatrin | Sabril | Treatment of infantile spasms.
Viloxazine HCl | Catatrol | Treatment of narcolepsy.
Viloxazine HCl | Catatrol | Treatment of cataplexy.
vincristine sulfate liposome injection | [NAME] | Treatment of acute lymphoblastic leukemia.
[NAME] liposomes | [NAME] (r) | Treatment of metastatic uveal melanoma.
Virulizin | Virulizin | Treatment of pancreatic cancer.
viscous budesonide |  | Treatment for pediatric eosinophilic esophagitis.
vistonuridine |  | An antidote in the treatment of 5-fluorouracil poisoning.
vorinostat |  | Treatment of multiple myeloma
vorinostat |  | Treatment of mesothelioma
Vx-001 |  | Treatment of telomerase reverse transcriptase (TERT) positive non-small cell lung cancer in HLA-A*0201 positive patients
Xenogeneic hepatocytes | HepatAssist Liver Assist System | Treatment of severe liver failure.
Yttrium (90Y) antiferritin polyclonal antibodies | Ferritarg P | Treatment of Hodgkin's disease.
Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody | [NAME] | Treatment of ovarian carcinoma.
Zalcitabine |  | Treatment of AIDS.
Zosuquidar trihydrochloride |  | Treatment of acute myeloid leukemia